<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Immunol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Immunology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32431714</article-id>
<article-id pub-id-type="pmc">7214791</article-id>
<article-id pub-id-type="doi">10.3389/fimmu.2020.00830</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular Insights Into the Causes of Human Thymic Hypoplasia With Animal Models</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bhalla</surname>
<given-names>Pratibha</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wysocki</surname>
<given-names>Christian A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/672725/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van Oers</surname>
<given-names>Nicolai S. C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/775483/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Immunology, The University of Texas Southwestern Medical Center</institution>, <addr-line>Dallas, TX</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Pediatrics, The University of Texas Southwestern Medical Center</institution>, <addr-line>Dallas, TX</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Microbiology, The University of Texas Southwestern Medical Center</institution>, <addr-line>Dallas, TX</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Ichiro Taniuchi, RIKEN Center for Integrative Medical Sciences (IMS), Japan</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Takeshi Nitta, The University of Tokyo, Japan; Melanie Vacchio, National Institutes of Health (NIH), United States</p>
</fn>
<corresp id="c001">*Correspondence: Nicolai S. C. van Oers <email>nicolai.vanoers@utsouthwestern.edu</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>830</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>2</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>4</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Bhalla, Wysocki and van Oers.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Bhalla, Wysocki and van Oers</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>22q11.2 deletion syndrome (DiGeorge), CHARGE syndrome, Nude/SCID and otofaciocervical syndrome type 2 (OTFCS2) are distinct clinical conditions in humans that can result in hypoplasia and occasionally, aplasia of the thymus. Thymic hypoplasia/aplasia is first suggested by absence or significantly reduced numbers of recent thymic emigrants, revealed in standard-of-care newborn screens for T cell receptor excision circles (TRECs). Subsequent clinical assessments will often indicate whether genetic mutations are causal to the low T cell output from the thymus. However, the molecular mechanisms leading to the thymic hypoplasia/aplasia in diverse human syndromes are not fully understood, partly because the problems of the thymus originate during embryogenesis. Rodent and Zebrafish models of these clinical syndromes have been used to better define the underlying basis of the clinical presentations. Results from these animal models are uncovering contributions of different cell types in the specification, differentiation, and expansion of the thymus. Cell populations such as epithelial cells, mesenchymal cells, endothelial cells, and thymocytes are variably affected depending on the human syndrome responsible for the thymic hypoplasia. In the current review, findings from the diverse animal models will be described in relation to the clinical phenotypes. Importantly, these results are suggesting new strategies for regenerating thymic tissue in patients with distinct congenital disorders.</p>
</abstract>
<kwd-group>
<kwd>thymus development</kwd>
<kwd>thymic hypoplasia</kwd>
<kwd>TECs</kwd>
<kwd>mesenchymal cells</kwd>
<kwd>22q11.2 deletion syndrome</kwd>
<kwd>
<italic>PAX1</italic>
</kwd>
<kwd>
<italic>FOXN1</italic>
</kwd>
<kwd>
<italic>CHD7</italic>
</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Office of Extramural Research, National Institutes of Health<named-content content-type="fundref-id">10.13039/100006955</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn002">Jeffrey Modell Foundation<named-content content-type="fundref-id">10.13039/100001245</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="176"></ref-count>
<page-count count="14"></page-count>
<word-count count="12315"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Thymic hypoplasia is a common transient condition seen in newborns, particularly for premature babies (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). A short-lived hypoplasia of the thymus can occur at any age due to infections, diverse forms of stress, pregnancy, alcoholism, malnutrition, and radiation exposure (<xref ref-type="bibr" rid="B3">3</xref>–<xref ref-type="bibr" rid="B5">5</xref>). In the elderly, a severe and everlasting involution of the thymic tissue is a well-recognized consequence of the aging process (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). There are several genetic disorders in humans that result in permanent hypoplasia or occasional aplasia of the thymus evident at birth. These genetic disorders often lead to severe combined immunodeficiency (SCID) (<xref ref-type="bibr" rid="B8">8</xref>). The mutations can be monogenic or multigenic, impacting either the patterning of the thymic anlage, the thymic stromal cell populations, and/or the developing thymocytes. The stromal cell populations include mesenchymal cells, TECs and endothelial cells. Clinical conditions known to impact these stromal cell populations are chromosome 22q11.2 deletion syndrome (22q11.2del), also referred to as DiGeorge syndrome, Coloboma-heart defects-atresia choanae-retardation of growth-genital abnormalities-ear (CHARGE) syndrome arising from mutations in <italic>Chromodomain Helicase DNA Binding Protein 7</italic> (<italic>CHD7</italic>), Nude/SCID due to autosomal recessive mutations in <italic>Forkhead Box N1</italic> (<italic>FOXN1</italic>), otofaciocervical syndrome type 2 (OTFCS2) due to mutations in <italic>PAX1</italic>, as well as mutations in <italic>TBX1</italic> (located within the chromosome 22q11.2 locus) and <italic>TBX2</italic> (<xref ref-type="table" rid="T1">Table 1</xref>) (<xref ref-type="bibr" rid="B9">9</xref>–<xref ref-type="bibr" rid="B17">17</xref>). Hypoplasia/aplasia of the thymus can also arise in a developing fetus via teratogen exposures; diabetic- or retinoic acid- induced embryopathies (<xref ref-type="bibr" rid="B18">18</xref>–<xref ref-type="bibr" rid="B21">21</xref>). In the current review, the genetic mutations that affect the stromal cell populations needed for the formation and/or function of the thymus are described. Since these mutations often influence the specification of the thymus during embryogenesis, detailed mechanistic insights have come from mouse, rat and even zebrafish models.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Stromal cell intrinsic causes of thymic hypoplasia (T<sup>−/lo</sup>B<sup>+</sup>NK<sup>+</sup>) from specific human clinical disorders.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Disease name</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Frequency in the population</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Genes Affected (# SNPs in ClinVar database<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref>)</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Thymic hypoplasia (% of patients)</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Mouse models</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Stromal cell populations affected</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">22q11.2 deletion syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">1 in 4000</td>
<td align="left" colspan="1" rowspan="1" valign="top">&gt;105 genes [46 coding, 7 miRNAs, 12 lncRNAs, 2 snoRNAs, rest are pseudogenes]</td>
<td align="left" colspan="1" rowspan="1" valign="top">60–70% &lt;1% with aplasia of the thymus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chromosome 16 ortholog deletions, <italic>Tbx1</italic> targeted mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stromal cells (mesenchymal, endothelial, epithelial)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CHARGE syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">1 in 8500-10,000</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>CHD7</italic> (SNPs = 973)</td>
<td align="left" colspan="1" rowspan="1" valign="top">50%</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Chd7</italic> knockout and knock-in lines</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neural crest cells (mesenchyme)-TECs</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nude/SCID<xref ref-type="table-fn" rid="TN2"><sup>b</sup></xref> and SCID</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rare</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>FOXN1</italic> (SNPs = 126)</td>
<td align="left" colspan="1" rowspan="1" valign="top">90%</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Foxn1</italic> knockout and knock-in lines</td>
<td align="left" colspan="1" rowspan="1" valign="top">cTECs and mTECs</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Otofaciocervical syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rare</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>PAX1</italic> (SNPS = 29)</td>
<td align="left" colspan="1" rowspan="1" valign="top">100%</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Undulated</italic> series and <italic>Pax1</italic> knockout lines</td>
<td align="left" colspan="1" rowspan="1" valign="top">Endodermally-derived epithelial cells</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">22q11.2-like cardiovascular and skeletal disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rare</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>TBX2</italic> (SNPs = 25)</td>
<td align="left" colspan="1" rowspan="1" valign="top">100%</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Tbx2</italic> knockout mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stromal cells</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Maternal diabetes</td>
<td align="left" colspan="1" rowspan="1" valign="top">3–9% of pregnancies</td>
<td align="left" colspan="1" rowspan="1" valign="top">Multiple genes e.g., <italic>CybpA1</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">18% of those needing thymic transplant</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gestational and pre-gestational diabetes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stromal (mesenchymal, epithelial, endothelial)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fetal retinoid syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">5–20% malformation rates in live births</td>
<td align="left" colspan="1" rowspan="1" valign="top">Multiple genes e.g., <italic>Tbx</italic>1, <italic>Tbx2, Bmp4, Foxn1</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">Unknown</td>
<td align="left" colspan="1" rowspan="1" valign="top">Retinoic acid injections Enzyme KO mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stromal (mesenchymal, epithelial, endothelial)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN1">
<label>a</label>
<p><italic>single nucleotide polymorphisms = SNPs, reported in ClinVar database</italic>.</p>
</fn>
<fn id="TN2">
<label>b</label>
<p><italic>severe combined immunodeficiency = SCID</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2">
<title>Review Article</title>
<sec>
<title>Overview of Murine Thymus Development During Embryogenesis</title>
<p>The thymus and parathyroid glands develop from the 3rd pharyngeal pouch (PP), a temporary embryonic structure that begins as an evagination of endothelial cells from the gut tube between e9.5–10.5 (<xref ref-type="fig" rid="F1">Figures 1A,B</xref>) (<xref ref-type="bibr" rid="B23">23</xref>). The formation of the 3rd PP requires several transcription factors including <italic>Paired box gene</italic> family members, <italic>Sin oculus homolog 1</italic> (<italic>Six1</italic>), and <italic>Eyes absent 1</italic> (<italic>Eya1</italic>) (<xref ref-type="bibr" rid="B23">23</xref>–<xref ref-type="bibr" rid="B25">25</xref>). As the 3rd PP forms, an endothelial layer within this region is surrounded by an area of neural crest-derived mesenchymal cells. Ectodermal in origin, these mesenchymal cells secrete bone morphogenic protein 4 (bmp4) and bone morphogenic protein 2 (bmp2) to support the patterning of the 3rd PP (<xref ref-type="bibr" rid="B26">26</xref>). The targeted deletion of <italic>bmp4</italic> in neural crest cells leads to a reduced contraction of the mesenchymal cells in the 3rd PP (<xref ref-type="bibr" rid="B26">26</xref>). This results in morphogenesis defects of both the thymus and parathyroid domains, which are delineated by the expression of <italic>Forkhead box n1</italic> (<italic>Foxn1</italic>) and <italic>Glia cells missing 2</italic> (<italic>Gcm2</italic>), respectively. The demarcation of the thymus domain by <italic>bmp4</italic> is balanced by <italic>Sonic hedgehog</italic> (Shh), which establishes the dorsal parathyroid region (<xref ref-type="bibr" rid="B27">27</xref>). Interestingly, the initial specification of the thymus and parathyroid regions can occur in the absence of neural crest cells, which are lacking in splotch mutant mice, which have mutations in the <italic>Paired box gene 3</italic> (<italic>Pax3</italic>) transcription factor (<xref ref-type="bibr" rid="B28">28</xref>). <italic>Paired box gene 1</italic> (<italic>Pax1</italic>) is a related family member also involved in the development of the thymic anlage (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B29">29</xref>). A <italic>Pax1</italic> deficiency in mice leads to mild hypoplasia of the thymus (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). Interestingly, <italic>PAX1</italic> autosomal recessive mutations in humans leads to a more severe hypoplasia of the thymus (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B17">17</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>The specification and expansion of the thymus during embryogenesis in normal and disease states. <bold>(A)</bold> Cartoon diagram illustrating the development process of the thymus along with the various transcription factors and gene products required. The genes that have roles in the specification of the human pharyngeal apparatus that affects the 3rd pharyngeal pouch (thymus and parathyroid) are shown in brown, while those confirmed importance for these processes in mice are in blue. <bold>(B)</bold> Transverse tissue sections or intact thymic lobes were isolated from normal embryos at the indicated ages of gestation. The transverse sections or whole mounts of the tissue were prepared for immunohistochemistry and H&amp;E staining. Antibodies against vascular smooth muscle, pdgfr-a (alpha) marking the mesenchymal cells and thymic capsule, pdgfr-b (beta) delineating mesenchymal cells and the vasculature, cytokeratin (TECs) and laminin were used, with the colors indicated below the image. <bold>(C)</bold> Thymocyte subset distributions present in e19–19.5 embryonic thymuses from control C57BL/6 mice, those modeling 22q11.2 deletion syndrome (Tbx1<sup>neo2/neo2</sup>) and those with compound heterozygous mutations in <italic>Foxn1</italic> (Foxn1<sup>933/1089</sup>) are shown. The <italic>Foxn1</italic> mutations genocopy that identified in a human patient (<xref ref-type="bibr" rid="B22">22</xref>). Both control and 22q11.2del thymuses have similar distributions of CD4 and CD8 thymocyte subset percentages, suggesting normal TEC functions. The <italic>Foxn1</italic> mutant mice are blocked at the CD4<sup>−</sup>CD8<sup>−</sup> subset, indicating a severe TEC dysfunction.</p>
</caption>
<graphic xlink:href="fimmu-11-00830-g0001"></graphic>
</fig>
<p>With regards to the stromal cell populations, the neural crest-derived mesenchymal cells have at least three distinct roles in the development of the thymic tissue. First, these cells form the thymic capsule and vasculature, establishing the overall structure of the thymus. Noteworthy, the mechanical removal of the mesenchymal capsule using e12.5 fetal thymic lobes renders the tissue hypoplastic (<xref ref-type="bibr" rid="B31">31</xref>–<xref ref-type="bibr" rid="B33">33</xref>). Yet, the development and proportions of thymocytes subsets are normal in these mesenchymal-depleted hypoplastic tissues, revealing intact TEC functions in the setting of their reduced numbers. Second, the mesenchymal cells enable the expanding thymic lobes to detach from the pharynx between e11.5–12.5, with each lobe from the right and left 3rd PP pairing and descending into the mediastinum. This process requires both <italic>Pax3</italic> and <italic>Homeobox a3 (Hoxa3</italic>) transcription factors, with the targeted deletion of <italic>Hoxa3</italic> in neural crest cells resulting in smaller sized thymic lobes remaining attached to the pharynx (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B34">34</xref>). Third, the mesenchymal cells support thymic epithelial cell (TECs) expansion and differentiation. This involves a combination of ligands and growth factors produced by mesenchymal cells; bmp4, bmp2, fibroblast and insulin growth factors, wnt proteins, and retinoic acid (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B35">35</xref>–<xref ref-type="bibr" rid="B38">38</xref>). Cross-talk between the mesenchymal cells and TECs facilitates thymic tissue expansion, differentiation of TECs into cortical and medullary subsets and recruitment of hematopoietic thymic seeding progenitors (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>). The hematopoietic progenitors arrive in timed waves, with the first cells appearing prior to the vascularization of the thymic tissue (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>). Following tissue vascularization and remodeling of the epithelia into a 3-dimensional meshwork, the thymic seeding progenitors enter through the cortical-medullary junction (<xref ref-type="bibr" rid="B41">41</xref>). These progenitor cells, through a process of cell-cell interactions with TECs, develop into thymocytes. Consistent with the theme of cross-communication among the various cell types in the thymus, ligands expressed by the thymocytes further support the differentiation and expansion of TECs. For example, immature thymocytes are needed for the proper expansion of cTECs during late stages of embryogenesis (<xref ref-type="bibr" rid="B43">43</xref>). The cortical TECs positively select T cells expressing the correct T cell receptor (Tcr) specificity for self-peptides embedded by major histocompatibility molecules (<xref ref-type="bibr" rid="B44">44</xref>–<xref ref-type="bibr" rid="B46">46</xref>). In addition, the emergence of mature SP thymocytes enhances mTEC differentiation and proliferation by releasing epidermal growth factor (Egf) and lymphotoxin and expressing CD40L and RANKL (<xref ref-type="bibr" rid="B47">47</xref>–<xref ref-type="bibr" rid="B49">49</xref>). The mTECs ensure deletion of potentially autoreactive T cells and enable T regulatory cell selection (<xref ref-type="bibr" rid="B44">44</xref>–<xref ref-type="bibr" rid="B46">46</xref>). Of note, there are some distinctions between mouse and human thymic tissue specification during embryogenesis (<xref ref-type="bibr" rid="B25">25</xref>). Differing contributions of <italic>Pax1</italic> and <italic>Pax9</italic> is one such example, as detailed in the section on otofaciocervical syndrome type 2 (<xref ref-type="bibr" rid="B17">17</xref>). In addition, unlike mice, both humans and rats express MHC class II on developing thymocytes and these cells can support the selection and maturation of CD4 single positive cells (<xref ref-type="bibr" rid="B50">50</xref>–<xref ref-type="bibr" rid="B52">52</xref>). Several articles in the current series “new insights into thymic functions during stress, aging, and in disease settings” as well as other reviews have provided detailed information about the development and contribution of TECs in thymopoiesis (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B54">54</xref>). The current review will focus on the TECs and other stromal cell types affected by selected clinical disorders.</p>
</sec>
<sec>
<title>22q11.2 Deletion Syndrome (DiGeorge Syndrome)</title>
<p>Chromosome 22q11.2 deletion syndrome (22q11.2del; OMIM #188400) is a common human disorder (frequency of 1/4000), resulting in variable and complex congenital malformations (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B55">55</xref>–<xref ref-type="bibr" rid="B58">58</xref>). The congenital defects can include thymic hypoplasia, outflow track problems of the heart, hypoparathyroidism, dysmorphic facial features, and/or other midline organ involvement (<xref ref-type="table" rid="T1">Table 1</xref>). Additional complications for children with 22q11.2del include developmental delay, and over time, neurological problems such as schizophrenia and autism, malignancy, and/or autoimmunity (<xref ref-type="bibr" rid="B57">57</xref>–<xref ref-type="bibr" rid="B61">61</xref>). Most individuals with 22q11.2del have a 3 Mb microdeletion on chromosome 22, resulting in a hemizygosity of nearly 106 genes (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B63">63</xref>). A smaller, nested deletion of 1.5 Mb creates a haploinsufficiency of 30 genes, which occurs in 5–8% of 22q11.2del patients (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B60">60</xref>).</p>
<p>Thymic hypoplasia is reported for 60–70% of individuals with 22q11.2del (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B64">64</xref>). Due to their thymic hypoplasia, 22q11.2del patients have an average 5-fold reduction in the number of T cell receptor excision circles (TRECs) compared to matched controls, with TRECs measuring the circulating naïve T cells emerging from the thymus (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B66">66</xref>). In rare cases a patient with 22q11.2del may have complete thymic aplasia, resulting in near-complete absence of autologous T cells, defined by &lt;50 naïve CD3<sup>+</sup> T cells per microliter of peripheral blood (<xref ref-type="bibr" rid="B14">14</xref>). An effective clinical treatment option for such a patient is an allogeneic thymic tissue transplant, first depleted of thymocytes prior to the placement of small fragments of this tissue within the quadricep muscles (<xref ref-type="bibr" rid="B67">67</xref>–<xref ref-type="bibr" rid="B70">70</xref>). The thymic stromal tissue consists of TECs, mesenchymal cells, and endothelial cells (<xref ref-type="bibr" rid="B71">71</xref>). Upon transplant, the stromal tissue recruits host-derived hematopoietic cells that mature into thymocytes (<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B72">72</xref>). A remarkable feature of this thymus transplantation procedure is the successful selection of TCR-expressing T cells recognizing peptides presented by host (recipient) antigen-presenting cells (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B73">73</xref>). However, the processes of both positive and negative selection and that of MHC restriction of the developing T cells are not completely understood in these thymic tissue transplants. The positive selection of host T cells in a donor thymus MHC (HLA) background could be caused by recipient-derived epithelial progenitor cells (<xref ref-type="bibr" rid="B74">74</xref>). Alternatively, the developing human thymocytes could promote positive selection as these cells express MHC class II molecules (<xref ref-type="bibr" rid="B50">50</xref>). When MHC class II is forcibly expressed on murine thymocytes, such cells can now positively select CD4 T cells (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>). The thymocyte-selected CD4 single positive cells formed in these mouse models are different than conventional CD4 T cells (<xref ref-type="bibr" rid="B75">75</xref>). They express the promyelocytic leukemia zinc finger protein (plzf) and produce both gamma-interferon and IL-4, reflecting more innate-like responses (<xref ref-type="bibr" rid="B75">75</xref>). The thymic transplants for 22q11.2del patients can additionally enable T regulatory cell development (<xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B76">76</xref>). In normal thymopoiesis, these Tregs develop through interactions with medullary TECs. Negative selection is similarly not well-understood following thymus tissue grafting, with the developing T cells tolerant to both the donor and host MHC (<xref ref-type="bibr" rid="B76">76</xref>). It is likely that host dendritic cells along with donor mTECs tolerizing/eliminating any developing T cells targeting either host and donor peptide-MHC complexes (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B76">76</xref>).</p>
<p>Not all 22q11.2del patients who have a severe hypoplasia of the thymus are grafted with an allogeneic thymus (<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B78">78</xref>). Thus, matched sibling and sometimes unrelated bone marrow transplants have been successfully used to treat 22q11.2del patients who have a severe thymic hypoplasia (limited TRECs) (<xref ref-type="bibr" rid="B77">77</xref>–<xref ref-type="bibr" rid="B81">81</xref>). The recipient 22q11.2del patients have normal T cell functions and humoral immunity, suggesting T cell reconstitution. However, the majority of the donor T cells have a memory phenotype and a limited TCR repertoire (<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B78">78</xref>). In the short term, there is no difference reported in the mortality for the patients receiving a thymic tissue vs. those with a bone marrow transplant (<xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B81">81</xref>). This conclusion will require a long-term longitudinal study comparing infection and survival rates with a larger cohort. However, the lack of naïve T cell development in the bone marrow recipients is of clinical concern for 22q11.2del patients and as described in subsequent sections, individuals with <italic>FOXN1</italic> and <italic>PAX1</italic> mutations (<xref ref-type="bibr" rid="B82">82</xref>).</p>
<p>An important take-home message from the clinical approaches to treat 22q11.2del patients is that the deletion primarily impacts the stromal cells of the thymus. Yet, which stromal cell type(s) is affected by 22q11.2del remains unknown. One group has analyzed thymuses isolated from 22q11.2del patients, available since this tissue is often removed to allow surgical access to the heart (<xref ref-type="bibr" rid="B83">83</xref>). The most distinguishing feature of the thymuses from 22q11.2del patients is its smaller size compared to age-matched control tissues (<xref ref-type="bibr" rid="B83">83</xref>). Thymopoiesis appears normal, as the percentage of CD4<sup>−</sup>CD8<sup>−</sup> (DN), CD4<sup>+</sup>CD8<sup>+</sup> (DP), and CD4<sup>+</sup>CD8<sup>−</sup>, and CD4<sup>−</sup>CD8<sup>+</sup> (SP) thymocyte subsets in the hypoplastic tissues is similar to that seen with control samples. The medullary region does appear smaller in the 22q11.2del samples, although the levels of a key gene expressed in medullary TECs, <italic>Autoimmune regulator</italic> (<italic>AIRE)</italic>, is not statistically different from controls (<xref ref-type="bibr" rid="B83">83</xref>). Yet, the number of thymic CD4<sup>+</sup>Foxp3<sup>+</sup> T regulatory cells (Tregs) is diminished in the hypoplastic lobes and these cells have less suppressive capabilities compared to controls (<xref ref-type="bibr" rid="B83">83</xref>). It remains unknown why this difference exists but may explain the higher prevalence of autoimmune cytopenias in the 22q11.2del cohort (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B84">84</xref>, <xref ref-type="bibr" rid="B85">85</xref>). The number of these CD4<sup>+</sup> Tregs is also decreased in peripheral tissues, but this arises from the generalized T cell lymphopenia affecting most T cell subsets in the setting of 22q11.2del (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B85">85</xref>–<xref ref-type="bibr" rid="B89">89</xref>).</p>
<p>The congenital hypoplasia/aplasia of the thymus caused by 22q11.2del occurs during the patterning of the pharyngeal apparatus in embryos (<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B90">90</xref>–<xref ref-type="bibr" rid="B92">92</xref>). This is best revealed in mice, as comparative analyses between normal embryos and those obtained from 22q11.2del mouse models suggest patterning defects of the pharyngeal pouches and arches (<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B90">90</xref>, <xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B93">93</xref>–<xref ref-type="bibr" rid="B95">95</xref>). The 22q11.2del mouse lines were initially developed with orthologous deletions on murine chromosome 16 to identify genes causal to the congenital malformations (<xref ref-type="table" rid="T2">Table 2</xref>). This led to the realization that the principal cause of the congenital defects was linked to a haploinsufficiency of the <italic>T-box Transcription Factor 1</italic> (<italic>TBX1</italic>) (<xref ref-type="bibr" rid="B90">90</xref>, <xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B93">93</xref>, <xref ref-type="bibr" rid="B94">94</xref>, <xref ref-type="bibr" rid="B96">96</xref>). TBX1 interacts with members of the Histone-lysine N-methyltransferase (KMT2)-family, activating the low level transcription of over 2,000 genes (<xref ref-type="bibr" rid="B97">97</xref>). Interestingly, the penetrance and severity of the congenital malformations due to a haploinsufficiency of <italic>TBX1</italic> varies considerably in the mouse models, which recapitulates the wide range of differences among individual 22q11.2del patients (<xref ref-type="table" rid="T2">Table 2</xref>). Emerging evidence suggests this variability is due to a combination of genetic and epigenetic regulators, both within and outside chromosome 22q11.2, which influence all the clinical phenotypes of 22q11.2del (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B99">99</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Mouse models of human clinical disorders leading to hypoplasia or aplasia of the thymus.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Genetic mutation</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Impact on the thymus</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Alopecia/nail cornification</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Stage of developmental block in thymopoiesis</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Mechanistic insights</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<bold>Mouse models of 22q11.2 deletion syndrome</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">LgDel</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rare mild hypoplasia</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">30 genes, including <italic>Tbx1</italic> are haploinsufficient causing partially penetrant cardiac anomalies, minimal effect on thymus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Df (16)A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rare mild hypoplasia</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Df1/+</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rare mild hypoplasia</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tbx1<sup>−/−</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">Aplasia</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">DN1<xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Early embryonic lethal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tbx1<sup>neo2/+</sup> and Tbx1<sup>neo/+</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mild hypoplasia</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">50 and 70% normal <italic>Tbx1</italic> levels, respectively, enabling a gene dosage analysis and showing Tbx1 key to congenital abnormalities</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tbx1<sup>+/−</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">Mild hypoplasia</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Tbx1</italic> haploinsufficient (see above with Df and Lg series)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tbx1<sup>neo2/neo2</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">Severe hypoplasia</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">35% normal <italic>Tbx1</italic> levels leads to more penetrant and severe congenital malformations</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top"><bold>Mouse models of CHARGE syndrome:</bold>
<italic><bold>Chd7</bold></italic>
<bold>mutations created</bold></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Chd7</italic> point mutations</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not reported</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">Affects the cardiac tissue and malformations of the ear canal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Chd 7</italic> ENU<xref ref-type="table-fn" rid="TN4"><sup>b</sup></xref> mutations</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not reported</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">12 distinct mutations matching human mutations. Phenotypes mimic human disorder</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Chd7</italic> gene trap</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not reported</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">Three mutations (exons 1, 4, and 34) with effects as with ENU</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Chd7</italic> gene knockout</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">Exon 2 targeted, clinical phenotypes as with humans</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Chd7</italic><sup>+/xk</sup> gene trap</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypoplasia</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">11% embryos affected, small and ectopic location of the thymus</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top"><bold>Mouse models of SCID and Nude/SCID:</bold>
<italic><bold>Foxn1</bold></italic>
<bold>mutant mice generated</bold></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Foxn1 nu/nu</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aplastic thymus</td>
<td align="left" colspan="1" rowspan="1" valign="top">YES</td>
<td align="left" colspan="1" rowspan="1" valign="top">DN1<xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Required for TEC development, differentiation Regulates epithelial cells in the skin and nail beds</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Foxn1</italic>ΔExon3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypoplastic thymus</td>
<td align="left" colspan="1" rowspan="1" valign="top">NO</td>
<td align="left" colspan="1" rowspan="1" valign="top">DN1<xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Required for TECs Normal hair and nail beds</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">i<italic>Foxn1</italic>Δ7,8</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypoplastic thymus</td>
<td align="left" colspan="1" rowspan="1" valign="top">NO</td>
<td align="left" colspan="1" rowspan="1" valign="top">DN2-DN3<xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Inducible deletion of Foxn1 causes a loss of thymic structure, reduced T cell output</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Foxn1</italic>
<sup>933/1089</sup>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Severe hypoplasia of the thymus</td>
<td align="left" colspan="1" rowspan="1" valign="top">NO</td>
<td align="left" colspan="1" rowspan="1" valign="top">DN1<xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Required for TEC development, differentiation. Normal hair and nail beds</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Foxn1</italic>
<sup>1089/1089</sup>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypoplastic thymus</td>
<td align="left" colspan="1" rowspan="1" valign="top">NO</td>
<td align="left" colspan="1" rowspan="1" valign="top">DP<xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">5 amino acid region required for DP<xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref> to SP<xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref>. Normal hair and nail beds</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top"><bold>Mouse models of Otofaciocervical syndrome:</bold>
<italic><bold>Pax1</bold></italic>
<bold>mutations</bold></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Undulated</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mild hypoplasia</td>
<td align="left" colspan="1" rowspan="1" valign="top">NO</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gly to Ser mutation causes reduced DNA binding activity. Affects the patterning of the thymic anlage</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Undulated short</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mild hypoplasia</td>
<td align="left" colspan="1" rowspan="1" valign="top">NO</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">125 kb region is deleted, including <italic>Pax1</italic> coding region. Affects the expression of a long non-coding RNA, which is lost while Nkx2.2 is increased</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Undulated extensive</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mild hypoplasia</td>
<td align="left" colspan="1" rowspan="1" valign="top">NO</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">Last exon of <italic>Pax1</italic> deleted. Affects the patterning of the thymic anlage</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Pax1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mild hypoplasia</td>
<td align="left" colspan="1" rowspan="1" valign="top">NO</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">Complete <italic>Pax1</italic> knockout. Affects the patterning of the thymic anlage</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN3">
<label>a</label>
<p><italic>Developmental stages of thymopoiesis: DN subset is CD4<sup>−</sup>CD8<sup>−</sup>; DN1, CD44<sup>+</sup>CD25<sup>−</sup>; DN2, CD44<sup>+</sup>CD25<sup>+</sup>; DN3, CD44<sup>−</sup>CD25<sup>+</sup>; DP, CD4<sup>+</sup>CD8<sup>+</sup> thymocyte subset; SP, CD4<sup>+</sup> CD8<sup>−</sup> and CD4<sup>−</sup>CD8<sup>+</sup> single positive subsets</italic>.</p>
</fn>
<fn id="TN4">
<label>b</label>
<p><italic>N-ethyl-N-nitrosourea = ENU</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In the mouse models, haploinsufficiency of <italic>Tbx1</italic> is generally not very penetrant in eliciting hypoplasia/aplasia of the thymus (<xref ref-type="bibr" rid="B90">90</xref>, <xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B94">94</xref>, <xref ref-type="bibr" rid="B96">96</xref>, <xref ref-type="bibr" rid="B100">100</xref>). By comparing embryos expressing varying levels of <italic>Tbx1</italic>, expression of this transcription factor at or below 35% normal values results in a more frequent and damaging thymic hypoplasia (<xref ref-type="bibr" rid="B101">101</xref>). Thymic hypoplasia resulting from the reduced levels of <italic>Tbx1</italic> are likely caused by developmental abnormalities in the pharyngeal region. However, the studies published to date have not concentrated on the 3rd PP. What is noticeably different are the 4th pharyngeal arches (PA), adjacent to the 3rd PPs, which are absent or developmentally delayed between day e9.5-11.5 of embryogenesis (<xref ref-type="fig" rid="F1">Figure 1B</xref>) (<xref ref-type="bibr" rid="B101">101</xref>, <xref ref-type="bibr" rid="B102">102</xref>). This impacts the patterning of the structures originating from the right and left 4<sup>th</sup> PA, causing a displaced right subclavian artery and interrupted aortic arch type B, respectively. Both cardiac presentations are common clinical phenotypes of human 22q11.2del (<xref ref-type="bibr" rid="B102">102</xref>). <italic>Tbx1</italic> is specifically expressed in the regions comprising the pharyngeal arches as well as in the endothelial layer that juxtaposes the developing parathyroid (<xref ref-type="bibr" rid="B103">103</xref>). It is not expressed in the thymic anlage, suggesting that <italic>Tbx1</italic> haploinsufficiency does not directly impact TECs, consistent with the observations that enforced expression of <italic>Tbx1</italic> within the 3<sup>rd</sup> PP actually represses TEC development (<xref ref-type="bibr" rid="B103">103</xref>). A plausible explanation for the thymic hypoplasia in 22q11.2del is that reduced levels of <italic>Tbx1</italic> in the pharyngeal region impact the neural crest-derived mesenchymal cells that surround the 3<sup>rd</sup> PP. The importance of these mesenchymal cells and other cell types has been more clearly revealed in <italic>Tbx1</italic>-null embryos. An immunohistochemical analysis of these embryos reveals an abnormal distribution of proteins involved in the formation of the extracellular matrix, cell adhesions, and cell-cell contact (vinculin, paxillin and collagen) (<xref ref-type="bibr" rid="B104">104</xref>). Changes in the expression patterns of these proteins affects the NCC-derived mesenchyme along with the epithelial cells in the second heart field (<xref ref-type="bibr" rid="B104">104</xref>). Such results strongly suggest that the NCC-derived mesenchymal cells surrounding the 3<sup>rd</sup> PP may also have abnormal mesenchymal and endothelial cell distributions required for the proper patterning of the 3<sup>rd</sup> PP. This is likely what causes a size restriction on the developing thymus. In one mouse model of 22q11.2del (Tbx1<sup>neo2/neo2</sup>), the embryonic thymus is size restricted yet still supports normal T cell development (<xref ref-type="table" rid="T2">Table 2</xref>, <xref ref-type="fig" rid="F1">Figure 1C</xref>). This indicates that the TECs are functional, matching the phenotype noted in the hypoplastic thymic lobes from 22q11.2del patients (<xref ref-type="bibr" rid="B83">83</xref>). In summary, mouse models of 22q11.2del strongly suggest that the initial developmental problems leading to thymic hypoplasia are coupled to mesenchymal cell defects. As the mesenchymal cells provide critical support functions for TECs, the consequence is reduced TEC expansion. Comparing 22q11.2del with other human clinical syndromes further supports this notion, as described next.</p>
</sec>
<sec>
<title>Charge Syndrome Due to <italic>Chromodomain Helicase DNA Binding Protein 7</italic> Mutation</title>
<p>Coloboma-heart defects-atresia choanae-retardation of growth-genital abnormalities-ear abnormalities (CHARGE) is a multi-syndromic congenital disease (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B105">105</xref>, <xref ref-type="bibr" rid="B106">106</xref>). Approximately 90% of CHARGE patients have mutations in <italic>Chromodomain Helicase DNA Binding Protein 7</italic> (<italic>CHD7</italic>) (OMIM# 0214800) (<xref ref-type="bibr" rid="B107">107</xref>). CHD7 is an ATP-dependent nucleosome remodeling factor, regulating chromatin accessibility and consequently, gene expression (<xref ref-type="bibr" rid="B108">108</xref>). CHD7 also positively regulates ribosomal RNA biogenesis in the nucleolus (<xref ref-type="bibr" rid="B109">109</xref>). Affecting an estimated 1 in every 10,000 humans, 953 mutations have so far been discovered in <italic>CHD7</italic> (ClinVar database). These include missense, non-sense, deletion, splicing, and frame-shift mutations, resulting in a loss-of-function of varying severity depending on the location and/or effect of the mutation on the protein (<xref ref-type="bibr" rid="B105">105</xref>, <xref ref-type="bibr" rid="B110">110</xref>). Patients with the CHARGE syndrome have immune system problems that contribute to their recurrent infections; otitis media, sinusitis, upper airway infections, pneumonia, and/or sepsis (<xref ref-type="bibr" rid="B106">106</xref>, <xref ref-type="bibr" rid="B111">111</xref>). These infections are most often attributed to malformations of the craniofacial region, the upper respiratory tract, and the 7th cranial nerve (facial innervation). Of note, the first descriptions of CHARGE suggested that the infectious issues were of low incidence (<xref ref-type="bibr" rid="B105">105</xref>). More recent reports reveal that immune system complications are far more prevalent, with developmental problems of the thymus additionally reported as causal to the increased susceptibility to infections (<xref ref-type="bibr" rid="B106">106</xref>, <xref ref-type="bibr" rid="B112">112</xref>). An immunological assessment of 59 CHARGE patients revealed that about 50% had a T<sup>−/lo</sup>B<sup>+</sup>NK<sup>+</sup> phenotype (<xref ref-type="bibr" rid="B106">106</xref>). Immunoglobulin levels and subclasses were normal in most of these CHARGE patients. The absolute numbers of B cells, including memory cells, were very similar to that in controls. The low T cell numbers were a consequence of a thymic dysfunction as TREC levels for these patients were reduced relative to normal controls. Chart reviews for 36 CHARGE patients who had cardiac surgeries revealed 16 of 36 had a hypoplasia or aplasia of the thymus (<xref ref-type="bibr" rid="B106">106</xref>). The prevalence of the thymic hypoplasia may be higher in embryos, as a small/absent thymus was noted in seven of 10 CHARGE fetuses described in one study (<xref ref-type="bibr" rid="B113">113</xref>).</p>
<p><italic>Chd7</italic> is required for the formation of the multipotent migratory neural crest cells that migrate throughout the body, establishing the bone, cartilage, peripheral nervous system, and cardiac structures (<xref ref-type="bibr" rid="B114">114</xref>). To understand the role of <italic>Chd7</italic> in CHARGE, especially given the varied congenital problems that can arise, various mouse models have been developed (<xref ref-type="bibr" rid="B115">115</xref>–<xref ref-type="bibr" rid="B118">118</xref>). The mouse models include those generated with gene-trapped ES cell lines, N-ethyl-N-nitrosourea (ENU) mutagenesis, targeted mutations in <italic>Chd7</italic>, and various floxed alleles of the gene (<xref ref-type="table" rid="T2">Table 2</xref>). Embryological analyses indicate that <italic>Chd7</italic> is expressed in the pharyngeal region, including the 3rd PP, the 4th PA, and the 1st PP, the latter forming the auditory tube and middle ear canal (<xref ref-type="bibr" rid="B119">119</xref>). As early as e10.5, the 4th PA is malformed or absent in 50% of the <italic>Chd7</italic> mutant embryos, resulting in an interrupted aortic arch type B and displaced right subclavian artery, just as with 22q11.2del (<xref ref-type="bibr" rid="B90">90</xref>). While most of the studies did not focus on thymus abnormalities, one group did report on this tissue. In this study, about 11% of e14.5 Chd7<sup>+/xk</sup> embryos were found to have irregularly shaped thymic lobes, smaller and more oblong in appearance along with some ectopic positioning (<xref ref-type="bibr" rid="B119">119</xref>). <italic>Chd7</italic> is expressed in the surrounding mesenchyme and at higher levels in TECs, suggesting that the <italic>Chd7</italic> mutations impact both neural crest-derived mesenchymal cells and TECs (<xref ref-type="bibr" rid="B115">115</xref>). Interestingly, modulation of retinoic acid (RA) levels <italic>in utero</italic> can limit the severity of the phenotypes resulting from the <italic>Chd7</italic> mutations (<xref ref-type="bibr" rid="B120">120</xref>, <xref ref-type="bibr" rid="B121">121</xref>). The clinical phenotypes due to retinoic acid embryopathies, including hypoplasia of the thymus, are discussed in a later section.</p>
<p>Complementing the murine models, Zebrafish studies have provided additional insights into how <italic>Chd7</italic> impacts thymic tissue specification. One technology commonly used in Zebrafish is a gene knockdown approach with morpholino oligonucleotides (MOs), creating morphants that have a block in transcript expression. <italic>Chd7</italic> morphants have a disrupted morphogenesis of the 3rd PP, with the migration and function of neural crest cells (NCCs) in this area impaired (<xref ref-type="bibr" rid="B122">122</xref>). Both bmp4 and bmp2 levels are significantly diminished in the chd7 morphants, again revealing the importance of these soluble proteins in establishing the thymus and parathyroid domains. At later developmental time points, the <italic>Chd7</italic> knockdown impairs the formation of the thymic capsule and vasculature. This is coupled with a reduced formation/expansion of the TECs that may involve impaired differentiation of the endothelial layer. Finally, the TECs have a substantial loss of <italic>Foxn1</italic> expression, providing a mechanistic basis for the hypoplasia due to TEC abnormalities (<xref ref-type="bibr" rid="B122">122</xref>). In summary, the <italic>Chd7</italic> knockdown impacts the NCC-derived mesenchymal cells along with the TECs, which suggests that CHARGE affects more stromal cell populations than 22q11.2del.</p>
</sec>
<sec>
<title>Nude/SCID and SCID Phenotypes Linked to <italic>FOXN1</italic> Mutations</title>
<p>Autosomal recessive mutations in the <italic>Forkhead Box N1</italic> (<italic>FOXN1</italic>) transcription factor cause a T<sup>−</sup>B<sup>+</sup>NK<sup>+</sup> SCID phenotype due to a thymic aplasia as well as alopecia universalis and nail plate dystrophy (OMIM #601705) (<xref ref-type="bibr" rid="B123">123</xref>–<xref ref-type="bibr" rid="B127">127</xref>). Three distinct autosomal recessive mutations in <italic>FOXN1</italic> have been reported for 10 patients to date, and these mutations result in a complete loss of protein function, impacting TECs and skin epithelial cells. Patients with compound heterozygous mutations in <italic>FOXN1</italic> have also been reported with an atypical phenotype, a thymic hypoplasia without the co-presenting alopecia and nail dystrophy (<xref ref-type="bibr" rid="B22">22</xref>). With the increasing number of infants noted to have low TRECs, the subsequent use of exome sequencing for them has uncovered many individuals with single allelic mutations in <italic>FOXN1</italic> (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B128">128</xref>). While such affected individuals will likely recover normal T cell numbers as one allele remains functional, it is unclear what impact such single allelic mutations will have on T cell output later in life (<xref ref-type="bibr" rid="B129">129</xref>). To date, about 131 distinct mutations in human <italic>FOXN1</italic> have been reported, and while many are benign, there are &gt;20 that have either complete or partial loss of function consequences (ClinVar database). The best clinical treatment option for patients with autosomal recessive or specific compound heterozygous mutations that contribute to a loss-of-function for <italic>FOXN1</italic> is a thymic tissue transplant (<xref ref-type="bibr" rid="B12">12</xref>). Yet, while bone marrow transplants have also been undertaken for such patients, the underlying defect lies with the TECs of the thymus (<xref ref-type="bibr" rid="B22">22</xref>). Paralleling the clinical findings with 22q11.2del, a thymic tissue transplant is the best option as this directly resolves the TEC anomalies.</p>
<p>In the thymus, <italic>Foxn1</italic> is the master transcriptional regulator of TEC development, supporting the differentiation of both cortical and medullary TEC subsets (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B130">130</xref>–<xref ref-type="bibr" rid="B132">132</xref>). These TEC subsets are critical for establishing the repertoire of TCR-expressing T cells that are selected to recognize but not respond to self-peptide/MHC complexes (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B131">131</xref>). Foxn1 is a 648 amino acid long transcription factor that contains DNA binding and transactivation domains, both required for protein function (<xref ref-type="bibr" rid="B133">133</xref>, <xref ref-type="bibr" rid="B134">134</xref>). The DNA binding domain of Foxn1 comprises three alpha helices, three beta sheets, and two loops (wings) (<xref ref-type="bibr" rid="B130">130</xref>, <xref ref-type="bibr" rid="B135">135</xref>). The 3rd helix and the 2nd winged segment interact with the major and minor grooves of DNA, respectively (<xref ref-type="bibr" rid="B130">130</xref>, <xref ref-type="bibr" rid="B135">135</xref>). The DNA binding sequence bound by <italic>Foxn1</italic> is GAa/cGC, present in about 500 target genes (<xref ref-type="bibr" rid="B132">132</xref>). The genes regulated by Foxn1 include keratins, keratin-associated proteins, cytokeratins, thymo-proteasome components, and cell surface proteins (<xref ref-type="bibr" rid="B132">132</xref>, <xref ref-type="bibr" rid="B136">136</xref>). These proteins are important for both cortical and medullary TEC functions along with the extrusion of the hair shaft through the dermal layers of the skin and for nail bed formation (<xref ref-type="bibr" rid="B132">132</xref>, <xref ref-type="bibr" rid="B137">137</xref>, <xref ref-type="bibr" rid="B138">138</xref>). In many of the promoter/enhancer elements bound by Foxn1, there are CREB and Tp63 binding sites, suggesting cooperative gene regulation by multiple transcription factors (<xref ref-type="bibr" rid="B132">132</xref>).</p>
<p>Mouse and rat models have greatly aided in delineating the functions of <italic>Foxn1</italic>. First and foremost was a spontaneously arising mutant mouse line, discovered in 1966, with a pronounced nude phenotype (<italic>nu/nu</italic>). Almost three decades passed before the mapping of the <italic>nu/nu</italic> allele to autosomal recessive mutations in <italic>Foxn1</italic> (<xref ref-type="bibr" rid="B130">130</xref>, <xref ref-type="bibr" rid="B134">134</xref>). The <italic>nu</italic> mutation results in a single base pair deletion in exon 3, causing a frameshift and almost no protein expression (<xref ref-type="bibr" rid="B130">130</xref>). The mice lack fur, whiskers, and nails (<xref ref-type="bibr" rid="B130">130</xref>, <xref ref-type="bibr" rid="B139">139</xref>, <xref ref-type="bibr" rid="B140">140</xref>). The thymus in the <italic>nu/nu</italic> mouse is a small cystic tissue that is unable to support TEC and consequently, thymocyte development (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B141">141</xref>). Such nude mice are commonly referred to as Nude/SCID given their combined lack of fur and T<sup>−</sup>B<sup>+</sup>NK<sup>+</sup> immune profile. An analysis of embryos from these mice show that <italic>Foxn</italic>1 is not required for the initial specification of the thymic region within the 3rd PP, but rather for the vascularization of this tissue along with TEC differentiation/expansion (<xref ref-type="bibr" rid="B142">142</xref>, <xref ref-type="bibr" rid="B143">143</xref>). Nude rats (<italic>rnuN, rnu</italic>) and cats (<italic>nu/nu</italic>) with autosomal recessive mutations in <italic>Foxn1</italic> have similarly been described, with the first nude rat actually found in 1953, prior to the mouse reports (<xref ref-type="bibr" rid="B130">130</xref>, <xref ref-type="bibr" rid="B144">144</xref>–<xref ref-type="bibr" rid="B146">146</xref>). While the <italic>nu</italic> and <italic>rnuN</italic> mutations prevent translation of the DNA binding and transactivation domains, much like the autosomal recessive <italic>FOXN1</italic> mutations in humans, <italic>rnu</italic> rats carry a mutation within exon 8, which creates a stop codon. This leads to the expression of a truncated protein (amino acids 1-473) lacking the transactivation domain. Characterizing this region revealed several aspartic acid residues essential for protein function (<xref ref-type="bibr" rid="B133">133</xref>). In an unrelated study, the introduction of a truncated <italic>Foxn1</italic> construct, wherein only exon 3 is deleted, blocks TEC development/expansion while allowing for hair extrusion and nail formation (<xref ref-type="bibr" rid="B147">147</xref>). It remains unclear how this occurs as both DNA binding and transactivation domains remain intact. In a separate cohort of mice developed to genocopy the compound heterozygous <italic>FOXN1</italic> mutations identified in an infant, the mice (Foxn1<sup>933/1089</sup>) had T<sup>−</sup>B<sup>+</sup>NK<sup>+</sup> immune profile with normal hair growth and nail extensions (<xref ref-type="bibr" rid="B22">22</xref>). Unlike 22q11.2del and CHARGE, these <italic>FOXN1</italic> mutations directly impact TEC development, causing a loss of both DP and SP thymocytes (<xref ref-type="fig" rid="F1">Figure 1C</xref>). One of the mutations in <italic>FOXN1</italic> (FOXN1<sup>1089</sup>) causes a loss of 5 amino acids at the very end of the DNA binding domain (p.W363C with a 5 amino acid loss). Knock-in mice harboring this mutation on both alleles (Foxn1<sup>1089/1089</sup>) have a selective block in thymopoiesis at the DP stage, with hair follicles and nails appearing normal (<xref ref-type="bibr" rid="B22">22</xref>). This 5-amino acid sequence is highly conserved with <italic>Foxn4</italic>, an ancestral ortholog of <italic>Foxn1</italic> (<xref ref-type="bibr" rid="B148">148</xref>). Interestingly, the cephalochordate species (lancelets) lack a thymus, and have a divergent sequence within this 5-amino acid stretch (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B148">148</xref>). This suggests this small sequence is important for the expansion of DP thymocytes and their positive selection into CD4<sup>+</sup> and CD8<sup>+</sup> subsets (<xref ref-type="bibr" rid="B22">22</xref>). There is a 2nd patient described with distinct compound heterozygous mutations in <italic>FOXN1</italic> (FOXN1<sup>1288/1465</sup>). In functional assays, one of the mutations (Foxn1<sup>1465</sup>) leads to a p.R489fsX61 truncation of the protein, resulting in 18% normal transcriptional activity (<xref ref-type="bibr" rid="B22">22</xref>). This mutation prevents the translation of the transactivation domain, revealing a requirement for this region to maintain normal TEC functions. Of note, an increasing number of single allelic <italic>FOXN1</italic> mutations are being reported for patients initially presenting with low TRECs (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B128">128</xref>). The subsequent characterization of these novel mutations will likely reveal the basis for the differential functions of <italic>FOXN1</italic> in TEC subsets vs. skin epithelial cells. Of note, one research group has identified a cis-regulatory element (RE) in the 1st intron of <italic>Foxn1</italic>, the targeting of which reduces TEC numbers and functions without any impact on skin epithelial cells (<xref ref-type="bibr" rid="B149">149</xref>). This RE is a target of the <italic>Foxn1</italic> DNA binding domain, revealing a positive autoregulatory loop (<xref ref-type="bibr" rid="B150">150</xref>). The possibility exists that human patients may contain such intronic <italic>FOXN1</italic> mutations, but these have not been reported to date as whole genome sequencing, which is not commonly done, would be required to uncover them.</p>
<p>Post-natally, <italic>Foxn1</italic> needs to be continuously expressed in TECs to maintain normal T cell output from the thymus (<xref ref-type="bibr" rid="B132">132</xref>). Thus, the inducible deletion of <italic>Foxn1</italic> in adult mice reduces thymic cellularity, and impacts the expansion of the DN1-DN4 subsets of thymocytes (<xref ref-type="bibr" rid="B132">132</xref>). In “old” mice, <italic>Foxn1</italic> levels in the thymus are reduced significantly, which partly explains the tissue involution (<xref ref-type="bibr" rid="B151">151</xref>–<xref ref-type="bibr" rid="B153">153</xref>). Restoring <italic>Foxn1</italic> in the aged thymus significantly improves thymic cellularity and T cell output (<xref ref-type="bibr" rid="B152">152</xref>–<xref ref-type="bibr" rid="B155">155</xref>). Taken together, the numerous human reports regarding single allelic mutations in <italic>FOXN1</italic> and the diverse mouse models are beginning to reveal key regulatory features of this critical transcription factor needed for T cell output throughout life.</p>
</sec>
<sec>
<title>Otofaciocervical Syndrome Type 2 (OTFCS2) and <italic>PAX1</italic> Mutations</title>
<p>Loss-of-function mutations in <italic>PAX1</italic> lead to skeletal defects along with thymic hypoplasia in patients, the latter contributing to the T<sup>−/lo</sup>B<sup>+</sup>NK<sup>+</sup> phenotype (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B17">17</xref>). Four such patients received bone marrow transplants (prior to identification of the <italic>PAX1</italic> homozygous mutations) in an attempt to correct their SCID presentations. Notably, the bone marrow transplants were unable to restore T cell development [reviewed in (<xref ref-type="bibr" rid="B17">17</xref>)]. The T cells, characterized in the patients after their bone marrow transplants, were of donor origin and exhibited a memory phenotype. Such findings are consistent with the current knowledge that <italic>PAX1</italic> regulates the patterning of the pharyngeal region, thereby impacting the stromal cell populations that would not be corrected by a bone marrow transplant.</p>
<p>Using embryos isolated from pregnant mice, <italic>Pax1</italic> transcripts are evident in the four pharyngeal pouches as early as e10.5, and become confined to mesenchymal condensations as embryogenesis progresses (<xref ref-type="bibr" rid="B29">29</xref>). This transcription factor is present in the 3rd PP endoderm and is subsequently detected in a subset of TECs during embryogenesis (<xref ref-type="bibr" rid="B29">29</xref>). Its expression is retained in the adult thymus. The deletion of <italic>Pax1</italic> results in a marginal hypoplasia of the thymus (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). This was reported in the <italic>undulated</italic> series of mouse lines that had varying mutations within <italic>Pax1</italic> or with surrounding regulatory elements. These mice were initially described in the 1940's due to their kinked tails and vertebral deformities (<xref ref-type="table" rid="T2">Table 2</xref>) (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B156">156</xref>). All <italic>undulated</italic> mutants have a smaller thymus about 2/3rd normal size (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). Interestingly, only in the context of a <italic>Hoxa3</italic> haploinsufficiency does the thymus in the <italic>Pax1</italic> mutant lines exhibit a more severe hypoplasia, with the two lobes ectopically positioned (<xref ref-type="bibr" rid="B30">30</xref>). The mild thymus phenotypes in the mouse models comprising various <italic>Pax1</italic> mutations sharply contrast the severe hypoplasia in humans with <italic>PAX1</italic> autosomal recessive mutations. One possible explanation is a compensatory contribution by murine <italic>Pax9</italic> when <italic>Pax1</italic> is lacking. <italic>Pax9</italic> overlaps in expression with <italic>Pax1</italic> in the endodermal-derived epithelium of the pharyngeal pouches (<xref ref-type="bibr" rid="B157">157</xref>). In mice, a complete deficiency of <italic>Pax9</italic> causes a thymic aplasia and a lack of teeth, while in humans, autosomal recessive mutations in <italic>PAX9</italic> cause selective tooth agenesis (<xref ref-type="bibr" rid="B158">158</xref>, <xref ref-type="bibr" rid="B159">159</xref>).</p>
</sec>
<sec>
<title>Clinical Conditions During Pregnancy Leading to a Thymic Hypoplasia/Aplasia</title>
<p>Maternal diabetes and systemic use of retinoic acid (RA) derivatives during pregnancy can cause long-term thymic hypoplasia in newborns (<xref ref-type="bibr" rid="B18">18</xref>–<xref ref-type="bibr" rid="B21">21</xref>). What's more, gestational diabetes leads to congenital malformations in the developing fetus which overlap with those noted in individuals with 22q11.2del; hypoplasia/aplasia of the thymus, cardiac outflow tract defects, and hypoparathyroidism (<xref ref-type="bibr" rid="B160">160</xref>–<xref ref-type="bibr" rid="B163">163</xref>). Estimates suggest that 18% of infants who required a thymic tissue transplant due to an aplasia of this tissue, and did not have 22q11.2del, were born to mothers who had maternal diabetes (<xref ref-type="bibr" rid="B72">72</xref>). In spite of the obvious overlap in clinical presentations between 22q11.2del and diabetic embryopathy, it remains unknown how blood sugar dysregulation affects the pharyngeal apparatus.</p>
<p>In rodent studies, the induction of diabetes in pregnant mice and rats causes thymic hypoplasia along with intrauterine growth impairment (<xref ref-type="bibr" rid="B164">164</xref>). While intrauterine growth delay will certainly contribute to thymic hypoplasia, there is some evidence that the hypoplasia can result from patterning defects within the pharyngeal apparatus. As gestational diabetes in rodent models is difficult to regulate, the use of a pregestational diabetes mouse model has revealed that retinoic acid production is dysregulated in the developing embryos. Thus, pregestational diabetes reduces the expression of <italic>Cytochrome P450 family 26 subfamily A member 1</italic> (<italic>Cyp26a1</italic>), an enzyme that catabolizes retinoic acid (RA) in the caudal region (tailbud) of developing embryos (<xref ref-type="bibr" rid="B165">165</xref>). RA is a derivative of Vitamin A, which functions as a natural morphogen regulating the patterning of the 3rd PP along with the 4th PA (<xref ref-type="bibr" rid="B166">166</xref>–<xref ref-type="bibr" rid="B170">170</xref>). Both reductions and elevations in RA can lead to hypoplasia of the thymus along with the other congenital malformations that overlap remarkably with 22q11.2del and CHARGE phenotypes (<xref ref-type="bibr" rid="B8">8</xref>). While the levels of Cyb26a1 or related family members within the pharyngeal region were not assessed in the pregestational diabetes model, their loses would increase RA, which could cause the problems of the thymus. Consistent with this, injecting high levels of RA in pregnant mice at e9.5 results in the formation of a hypoplastic/aplastic thymus, examined at e11.5–e12.5 (<xref ref-type="bibr" rid="B21">21</xref>). It is known that high levels of RA can impair the migration of the NCCs in the region surrounding the 3rd PP (<xref ref-type="bibr" rid="B21">21</xref>). Moreover, high levels of RA can reduce the expression of <italic>Pax1</italic> within the 3rd PP and <italic>Tbx1</italic> throughout the pharyngeal apparatus (<xref ref-type="bibr" rid="B171">171</xref>–<xref ref-type="bibr" rid="B173">173</xref>). RA likewise represses Bmp4 activity, impacting thymic tissue specification and development by ultimately reducing the levels of <italic>Foxn1</italic> (<xref ref-type="bibr" rid="B174">174</xref>). These changes have some similarity to that described for embryos developing in the setting of <italic>Chd7</italic> mutations.</p>
<p>The second medical condition that can lead to permanent hypo- or aplasia of the thymus in newborns is exposure to elevated levels of RA during pregnancy. Drugs such as tretinoin or isotretinoin are retinoids prescribed to patients to both reduce the severity of their acne and smoothen the skin. However, if taken during pregnancy, the higher levels of RA can trigger 22q11.2-like congenital malformations in the developing embryos (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B160">160</xref>–<xref ref-type="bibr" rid="B162">162</xref>, <xref ref-type="bibr" rid="B175">175</xref>, <xref ref-type="bibr" rid="B176">176</xref>). The mechanism for this hypoplasia is a combination of <italic>Tbx1, Pax1</italic>, and <italic>Foxn1</italic> suppression, as described in the preceding sections of this review (<xref ref-type="fig" rid="F1">Figure 1A</xref>). The profound damage caused by RA has led to a generalized warning from the FDA for women to avoid treatments with RA derivatives during pregnancy.</p>
</sec>
</sec>
<sec id="s3" sec-type="conclusions">
<title>Conclusion</title>
<p>A number of clinical conditions impact the specification of the thymus during embryogenesis. Interestingly, those that affect the stromal cell populations have overlapping phenotypes, revealing that many of the affected genes function in related developmental pathways. 22q11.2del appears to impact one of the earlier stromal cell types involved in this process, the NCC-derived mesenchymal cells. These cells regulate the patterning and formation of the thymic anlage. CHARGE affects mesenchymal cells, endothelial cells and the TECs, while <italic>FOXN1</italic> mutations selectively affect the TECs. It is becoming obvious that the three stromal cell types have considerable cross-talk to coordinate the formation and expansion of the thymus. A balanced interplay among all three is essential for the normal specification and expansion of the thymic tissue. Variations in the functions of any one of these stromal cell populations will impact the other, which likely explains the overlapping clinical phenotypes noted among affected individuals.</p>
</sec>
<sec id="s4">
<title>Ethics Statement</title>
<p>Animal work described in this article has been approved and conducted under the oversight of the UT Southwestern Institutional Animal Care and Use Committee (APN numbers: 2015-101163 and 2015-101247).</p>
</sec>
<sec id="s5">
<title>Author Contributions</title>
<p>PB and NO generated the figures. PB, CW, and NO wrote and modified the manuscript.</p>
</sec>
<sec id="s6">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>We would like to thank Ms. Fatma Coskun and Mr. Austin Thompson for critically reviewing the manuscript, the figures, and for helpful discussions (UT Southwestern Medical Center). We also thanks Drs. Maria Teresa de la Morena (Seattle Children's Hospital, Seattle, WA) and M. Louise Markert (Duke University) for ongoing information and feedback concerning clinical presentations for patients with 22q11.2del and <italic>FOXN1</italic> mutations.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> Our work was supported, in part, by grants from the National Institutes of Health R01 (R01 AI114523, R21 AI144140 NO), Beecherl funds from the Department of Immunology at UT Southwestern Medical Center (NO), and the Jeffery Modell Foundation (CW).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname><given-names>A</given-names></name><name><surname>Abraham</surname><given-names>RS</given-names></name><name><surname>Currier</surname><given-names>R</given-names></name><name><surname>Brower</surname><given-names>A</given-names></name><name><surname>Andruszewski</surname><given-names>K</given-names></name><name><surname>Abbott</surname><given-names>JK</given-names></name><etal></etal></person-group>. <article-title>Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States</article-title>. <source/>JAMA. (<year>2014</year>) <volume>312</volume>:<fpage>729</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2014.9132</pub-id><pub-id pub-id-type="pmid">25138334</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amatuni</surname><given-names>GS</given-names></name><name><surname>Currier</surname><given-names>RJ</given-names></name><name><surname>Church</surname><given-names>JA</given-names></name><name><surname>Bishop</surname><given-names>T</given-names></name><name><surname>Grimbacher</surname><given-names>E</given-names></name><name><surname>Nguyen</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Newborn screening for severe combined immunodeficiency and T-cell Lymphopenia in California, 2010–2017</article-title>. <source/>Pediatrics. (<year>2019</year>) <volume>143</volume>:<fpage>e20182300</fpage>. <pub-id pub-id-type="doi">10.1542/peds.2018-2300</pub-id><pub-id pub-id-type="pmid">30683812</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruver</surname><given-names>AL</given-names></name><name><surname>Sempowski</surname><given-names>GD</given-names></name></person-group>. <article-title>Cytokines, leptin, and stress-induced thymic atrophy</article-title>. <source/>J Leukocyte Biol. (<year>2008</year>) <volume>84</volume>:<fpage>915</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0108025</pub-id><pub-id pub-id-type="pmid">18495786</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkaya</surname><given-names>S</given-names></name><name><surname>Silge</surname><given-names>RL</given-names></name><name><surname>Hoover</surname><given-names>AR</given-names></name><name><surname>Medeiros</surname><given-names>JJ</given-names></name><name><surname>Eitson</surname><given-names>JL</given-names></name><name><surname>Becker</surname><given-names>AM</given-names></name><etal></etal></person-group>. <article-title>Dynamic modulation of thymic microRNAs in response to stress</article-title>. <source/>PLoS ONE. (<year>2011</year>) <volume>6</volume>:<fpage>e27580</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0027580</pub-id><pub-id pub-id-type="pmid">22110677</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhry</surname><given-names>MS</given-names></name><name><surname>Velardi</surname><given-names>E</given-names></name><name><surname>Dudakov</surname><given-names>JA</given-names></name><name><surname>Van Den Brink</surname><given-names>MRM</given-names></name></person-group>. <article-title>Thymus: the next (re)generation</article-title>. <source/>Immunol Rev. (<year>2016</year>) <volume>271</volume>:<fpage>56</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1111/imr.12418</pub-id><pub-id pub-id-type="pmid">27088907</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gui</surname><given-names>J</given-names></name><name><surname>Mustachio</surname><given-names>L</given-names></name><name><surname>Su</surname><given-names>D-M</given-names></name><name><surname>Craig</surname><given-names>RW</given-names></name></person-group>. <article-title>Thymus size and age-related thymic involution: early programming, sexual dimorphism, progenitors and stroma</article-title>. <source/>Aging Dis. (<year>2012</year>) <volume>3</volume>:<fpage>280</fpage>−<lpage>90</lpage>.<pub-id pub-id-type="pmid">22724086</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>D</given-names></name></person-group>. <article-title>The effect of age on thymic function</article-title>. <source/>Front Immunol. (<year>2013</year>) <volume>4</volume>:<fpage>316</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2013.00316</pub-id><pub-id pub-id-type="pmid">24109481</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>Q</given-names></name><name><surname>De La Morena</surname><given-names>MT</given-names></name><name><surname>Van Oers</surname><given-names>NS</given-names></name></person-group>
<article-title>The genetics and epigenetics of 22q11.2 deletion syndromes</article-title>. <source/>Front Genet. (<year>2020</year>) <volume>10</volume>:<fpage>1365</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2019.01365</pub-id><pub-id pub-id-type="pmid">32117416</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yagi</surname><given-names>H</given-names></name><name><surname>Furutani</surname><given-names>Y</given-names></name><name><surname>Hamada</surname><given-names>H</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Asakawa</surname><given-names>S</given-names></name><name><surname>Minoshima</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Role of TBX1 in human del22q11.2 syndrome</article-title>. <source/>Lancet. (<year>2003</year>) <volume>362</volume>:<fpage>1366</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(03)14632-6</pub-id><pub-id pub-id-type="pmid">14585638</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zweier</surname><given-names>C</given-names></name><name><surname>Sticht</surname><given-names>H</given-names></name><name><surname>Aydin-Yaylagul</surname><given-names>I</given-names></name><name><surname>Campbell</surname><given-names>CE</given-names></name><name><surname>Rauch</surname><given-names>A</given-names></name></person-group>. <article-title>Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions</article-title>. <source/>Am J Hum Genet. (<year>2007</year>) <volume>80</volume>:<fpage>510</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1086/511993</pub-id><pub-id pub-id-type="pmid">17273972</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gennery</surname><given-names>AR</given-names></name><name><surname>Slatter</surname><given-names>MA</given-names></name><name><surname>Rice</surname><given-names>J</given-names></name><name><surname>Hoefsloot</surname><given-names>LH</given-names></name><name><surname>Barge</surname><given-names>D</given-names></name><name><surname>Mclean-Tooke</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Mutations in CHD7 in patients with CHARGE syndrome cause T–B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome</article-title>. <source/>Clin Exp Immunol. (<year>2008</year>) <volume>153</volume>:<fpage>75</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2008.03681.x</pub-id><pub-id pub-id-type="pmid">18505430</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markert</surname><given-names>ML</given-names></name><name><surname>Marques</surname><given-names>JG</given-names></name><name><surname>Neven</surname><given-names>B</given-names></name><name><surname>Devlin</surname><given-names>BH</given-names></name><name><surname>Mccarthy</surname><given-names>EA</given-names></name><name><surname>Chinn</surname><given-names>IK</given-names></name><etal></etal></person-group>. <article-title>First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases</article-title>. <source/>Blood. (<year>2011</year>) <volume>117</volume>:<fpage>688</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2010-06-292490</pub-id><pub-id pub-id-type="pmid">20978268</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pohl</surname><given-names>E</given-names></name><name><surname>Aykut</surname><given-names>A</given-names></name><name><surname>Beleggia</surname><given-names>F</given-names></name><name><surname>Karaca</surname><given-names>E</given-names></name><name><surname>Durmaz</surname><given-names>B</given-names></name><name><surname>Keupp</surname><given-names>K</given-names></name><etal></etal></person-group>. <article-title>A hypofunctional PAX1 mutation causes autosomal recessively inherited otofaciocervical syndrome</article-title>. <source/>Hum Genet. (<year>2013</year>) <volume>132</volume>:<fpage>1311</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-013-1337-9</pub-id><pub-id pub-id-type="pmid">23851939</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morsheimer</surname><given-names>M</given-names></name><name><surname>Brown Whitehorn</surname><given-names>TF</given-names></name><name><surname>Heimall</surname><given-names>J</given-names></name><name><surname>Sullivan</surname><given-names>KE</given-names></name></person-group>. <article-title>The immune deficiency of chromosome 22q11.2 deletion syndrome</article-title>. <source/>Am J Med Genet A. (<year>2017</year>) <volume>173</volume>:<fpage>2366</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.38319</pub-id><pub-id pub-id-type="pmid">28627729</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paganini</surname><given-names>I</given-names></name><name><surname>Sestini</surname><given-names>R</given-names></name><name><surname>Capone</surname><given-names>GL</given-names></name><name><surname>Putignano</surname><given-names>AL</given-names></name><name><surname>Contini</surname><given-names>E</given-names></name><name><surname>Giotti</surname><given-names>I</given-names></name><etal></etal></person-group>. <article-title>A novel PAX1 null homozygous mutation in autosomal recessive otofaciocervical syndrome associated with severe combined immunodeficiency</article-title>. <source/>Clin Genet. (<year>2017</year>) <volume>92</volume>:<fpage>664</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/cge.13085</pub-id><pub-id pub-id-type="pmid">28657137</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Schoch</surname><given-names>K</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Pena</surname><given-names>LDM</given-names></name><name><surname>Bhavana</surname><given-names>VH</given-names></name><name><surname>Kukolich</surname><given-names>MK</given-names></name><etal></etal></person-group>. <article-title>Functional variants in TBX2 are associated with a syndromic cardiovascular and skeletal developmental disorder</article-title>. <source/>Hum Mol Genet. (<year>2018</year>) <volume>27</volume>:<fpage>2454</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddy146</pub-id><pub-id pub-id-type="pmid">29726930</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname><given-names>Y</given-names></name><name><surname>Urrutia</surname><given-names>R</given-names></name><name><surname>Franco</surname><given-names>LM</given-names></name><name><surname>Giliani</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Alazami</surname><given-names>AM</given-names></name><etal></etal></person-group>. <article-title>PAX1 is essential for development and function of the human thymus</article-title>. <source/>Sci Immunol. (<year>2020</year>) <volume>5</volume>:<fpage>eaax1036</fpage>. <pub-id pub-id-type="doi">10.1126/sciimmunol.aax1036</pub-id><pub-id pub-id-type="pmid">32111619</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lammer</surname><given-names>EJ</given-names></name><name><surname>Chen</surname><given-names>DT</given-names></name><name><surname>Hoar</surname><given-names>RM</given-names></name><name><surname>Agnish</surname><given-names>ND</given-names></name><name><surname>Benke</surname><given-names>PJ</given-names></name><name><surname>Braun</surname><given-names>JT</given-names></name><etal></etal></person-group>. <article-title>Retinoic acid embryopathy</article-title>. <source/>N Engl J Med. (<year>1985</year>) <volume>313</volume>:<fpage>837</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM198510033131401</pub-id><pub-id pub-id-type="pmid">3162101</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novak</surname><given-names>RW</given-names></name><name><surname>Robinson</surname><given-names>HB</given-names></name></person-group>. <article-title>Coincident DiGeorge anomaly and renal agenesis and its relation to maternal diabetes</article-title>. <source/>Am J Med Genet. (<year>1994</year>) <volume>50</volume>:<fpage>311</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.1320500402</pub-id><pub-id pub-id-type="pmid">8209907</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Digilio</surname><given-names>MC</given-names></name><name><surname>Marino</surname><given-names>B</given-names></name><name><surname>Formigari</surname><given-names>R</given-names></name><name><surname>Giannotti</surname><given-names>A</given-names></name></person-group>. <article-title>Maternal diabetes causing DiGeorge anomaly and renal agenesis</article-title>. <source/>Am J Med Genet. (<year>1995</year>) <volume>55</volume>:<fpage>513</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.1320550427</pub-id><pub-id pub-id-type="pmid">7762600</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulder</surname><given-names>GB</given-names></name><name><surname>Manley</surname><given-names>N</given-names></name><name><surname>Maggio-Price</surname><given-names>L</given-names></name></person-group>. <article-title>Retinoic acid-induced thymic abnormalities in the mouse are associated with altered pharyngeal morphology, thymocyte maturation defects, and altered expression of Hoxa3 and Pax1</article-title>. <source/>Teratology. (<year>1998</year>) <volume>58</volume>:<fpage>263</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1096-9926(199812)58:6&lt;263::Aid-tera8&gt;3.0.Co;2-a</pub-id><pub-id pub-id-type="pmid">9894676</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>Q</given-names></name><name><surname>Huynh</surname><given-names>LK</given-names></name><name><surname>Coskun</surname><given-names>F</given-names></name><name><surname>Molina</surname><given-names>E</given-names></name><name><surname>King</surname><given-names>MA</given-names></name><name><surname>Raj</surname><given-names>P</given-names></name><etal></etal></person-group>. <article-title>FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in humans</article-title>. <source/>J Clin Invest. (<year>2019</year>) <volume>129</volume>:<fpage>4724</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1172/JCI127565</pub-id><pub-id pub-id-type="pmid">31566583</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>J</given-names></name><name><surname>Manley</surname><given-names>NR</given-names></name></person-group>. <article-title>Mechanisms of thymus organogenesis and morphogenesis</article-title>. <source/>Development. (<year>2011</year>) <volume>138</volume>:<fpage>3865</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1242/dev.059998</pub-id><pub-id pub-id-type="pmid">21862553</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>PX</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>Laclef</surname><given-names>C</given-names></name><name><surname>Maire</surname><given-names>P</given-names></name><name><surname>Maas</surname><given-names>RL</given-names></name><name><surname>Peters</surname><given-names>H</given-names></name><etal></etal></person-group>. <article-title>Eya1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid</article-title>. <source/>Development. (<year>2002</year>) <volume>129</volume>:<fpage>3033</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">12070080</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farley</surname><given-names>AM</given-names></name><name><surname>Morris</surname><given-names>LX</given-names></name><name><surname>Vroegindeweij</surname><given-names>E</given-names></name><name><surname>Depreter</surname><given-names>ML</given-names></name><name><surname>Vaidya</surname><given-names>H</given-names></name><name><surname>Stenhouse</surname><given-names>FH</given-names></name><etal></etal></person-group>. <article-title>Dynamics of thymus organogenesis and colonization in early human development</article-title>. <source/>Development. (<year>2013</year>) <volume>140</volume>:<fpage>2015</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1242/dev.087320</pub-id><pub-id pub-id-type="pmid">23571219</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>J</given-names></name><name><surname>Patel</surname><given-names>SR</given-names></name><name><surname>Mishina</surname><given-names>Y</given-names></name><name><surname>Manley</surname><given-names>NR</given-names></name></person-group>. <article-title>Evidence for an early role for BMP4 signaling in thymus and parathyroid morphogenesis</article-title>. <source/>Dev Biol. (<year>2010</year>) <volume>339</volume>:<fpage>141</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2009.12.026</pub-id><pub-id pub-id-type="pmid">20043899</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore-Scott</surname><given-names>BA</given-names></name><name><surname>Manley</surname><given-names>NR</given-names></name></person-group>. <article-title>Differential expression of Sonic hedgehog along the anterior–posterior axis regulates patterning of pharyngeal pouch endoderm and pharyngeal endoderm-derived organs</article-title>. <source/>Dev Biol. (<year>2005</year>) <volume>278</volume>:<fpage>323</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2004.10.027</pub-id><pub-id pub-id-type="pmid">15680353</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>AV</given-names></name><name><surname>Cardenas</surname><given-names>K</given-names></name><name><surname>Carter</surname><given-names>C</given-names></name><name><surname>Gordon</surname><given-names>J</given-names></name><name><surname>Iberg</surname><given-names>A</given-names></name><name><surname>Engleka</surname><given-names>K</given-names></name><etal></etal></person-group>. <article-title>Increased thymus- and decreased parathyroid-fated organ domains in Splotch mutant embryos</article-title>. <source/>Dev Biol. (<year>2009</year>) <volume>327</volume>:<fpage>216</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2008.12.019</pub-id><pub-id pub-id-type="pmid">19135046</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallin</surname><given-names>J</given-names></name><name><surname>Eibel</surname><given-names>H</given-names></name><name><surname>Neubuser</surname><given-names>A</given-names></name><name><surname>Wilting</surname><given-names>J</given-names></name><name><surname>Koseki</surname><given-names>H</given-names></name><name><surname>Balling</surname><given-names>R</given-names></name></person-group>. <article-title>Pax1 is expressed during development of the thymus epithelium and is required for normal T-cell maturation</article-title>. <source/>Development. (<year>1996</year>) <volume>122</volume>:<fpage>23</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">8565834</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>D-M</given-names></name><name><surname>Manley</surname><given-names>NR</given-names></name></person-group>. <article-title>Hoxa3 and Pax1 transcription factors regulate the ability of fetal thymic epithelial cells to promote thymocyte development</article-title>. <source/>J Immunol. (<year>2000</year>) <volume>164</volume>:<fpage>5753</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.164.11.5753</pub-id><pub-id pub-id-type="pmid">10820253</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerbach</surname><given-names>R</given-names></name></person-group>. <article-title>Morphogenetic interactions in the development of the mouse thymus gland</article-title>. <source/>Dev Biol. (<year>1960</year>) <volume>2</volume>:<fpage>271</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/0012-1606(60)90009-9</pub-id><pub-id pub-id-type="pmid">13795076</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkinson</surname><given-names>WE</given-names></name><name><surname>Jenkinson</surname><given-names>EJ</given-names></name><name><surname>Anderson</surname><given-names>G</given-names></name></person-group>. <article-title>Differential requirement for mesenchyme in the proliferation and maturation of thymic epithelial progenitors</article-title>. <source/>J Exp Med. (<year>2003</year>) <volume>198</volume>:<fpage>325</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20022135</pub-id><pub-id pub-id-type="pmid">12860931</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkinson</surname><given-names>WE</given-names></name><name><surname>Rossi</surname><given-names>SW</given-names></name><name><surname>Parnell</surname><given-names>SM</given-names></name><name><surname>Jenkinson</surname><given-names>EJ</given-names></name><name><surname>Anderson</surname><given-names>G</given-names></name></person-group>. <article-title>PDGFRalpha-expressing mesenchyme regulates thymus growth and the availability of intrathymic niches</article-title>. <source/>Blood. (<year>2007</year>) <volume>109</volume>:<fpage>954</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2006-05-023143</pub-id><pub-id pub-id-type="pmid">17008543</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Wells</surname><given-names>L</given-names></name><name><surname>Amemiya</surname><given-names>CT</given-names></name><name><surname>Condie</surname><given-names>BG</given-names></name><name><surname>Manley</surname><given-names>NR</given-names></name></person-group>
<article-title>Mouse and zebrafish Hoxa3 orthologues have non-equivalent <italic>in vivo</italic> protein function</article-title>. <source/>Proc Natl Acad Sci. (<year>2010</year>) <volume>107</volume>:<fpage>10555</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1005129107</pub-id><pub-id pub-id-type="pmid">20498049</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>DU</given-names></name><name><surname>Fotheringham</surname><given-names>LK</given-names></name><name><surname>Brewer</surname><given-names>JA</given-names></name><name><surname>Muglia</surname><given-names>LJ</given-names></name><name><surname>Tristani-Firouzi</surname><given-names>M</given-names></name><name><surname>Capecchi</surname><given-names>MR</given-names></name><etal></etal></person-group>. <article-title>An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome</article-title>. <source/>Development. (<year>2002</year>) <volume>129</volume>:<fpage>4591</fpage>–<lpage>603</lpage>.<pub-id pub-id-type="pmid">12223415</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoi</surname><given-names>M</given-names></name><name><surname>Tsukamoto</surname><given-names>N</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Amagai</surname><given-names>T</given-names></name></person-group>. <article-title>Mesenchymal cells are required for functional development of thymic epithelial cells</article-title>. <source/>Int Immunol. (<year>2007</year>) <volume>19</volume>:<fpage>953</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1093/intimm/dxm060</pub-id><pub-id pub-id-type="pmid">17625108</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sitnik</surname><given-names>KM</given-names></name><name><surname>Kotarsky</surname><given-names>K</given-names></name><name><surname>White</surname><given-names>AJ</given-names></name><name><surname>Jenkinson</surname><given-names>WE</given-names></name><name><surname>Anderson</surname><given-names>G</given-names></name><name><surname>Agace</surname><given-names>WW</given-names></name></person-group>. <article-title>Mesenchymal cells regulate retinoic acid receptor-dependent cortical thymic epithelial cell homeostasis</article-title>. <source/>J Immunol. (<year>2012</year>) <volume>188</volume>:<fpage>4801</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1200358</pub-id><pub-id pub-id-type="pmid">22504647</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bleul</surname><given-names>CC</given-names></name><name><surname>Boehm</surname><given-names>T</given-names></name></person-group>. <article-title>BMP signaling is required for normal thymus development</article-title>. <source/>J Immunol. (<year>2005</year>) <volume>175</volume>:<fpage>5213</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.175.8.5213</pub-id><pub-id pub-id-type="pmid">16210626</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoi</surname><given-names>M</given-names></name><name><surname>Kawamoto</surname><given-names>H</given-names></name><name><surname>Katsura</surname><given-names>Y</given-names></name><name><surname>Amagai</surname><given-names>T</given-names></name></person-group>. <article-title>Two distinct steps of immigration of hematopoietic progenitors into the early thymus anlage</article-title>. <source/>Int Immunol. (<year>2001</year>) <volume>13</volume>:<fpage>1203</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1093/intimm/13.9.1203</pub-id><pub-id pub-id-type="pmid">11526101</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkinson</surname><given-names>WE</given-names></name><name><surname>Bacon</surname><given-names>A</given-names></name><name><surname>White</surname><given-names>AJ</given-names></name><name><surname>Anderson</surname><given-names>G</given-names></name><name><surname>Jenkinson</surname><given-names>EJ</given-names></name></person-group>. <article-title>An epithelial progenitor pool regulates thymus growth</article-title>. <source/>J Immunol. (<year>2008</year>) <volume>181</volume>:<fpage>6101</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.181.9.6101</pub-id><pub-id pub-id-type="pmid">18941199</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luis</surname><given-names>TC</given-names></name><name><surname>Luc</surname><given-names>S</given-names></name><name><surname>Mizukami</surname><given-names>T</given-names></name><name><surname>Boukarabila</surname><given-names>H</given-names></name><name><surname>Thongjuea</surname><given-names>S</given-names></name><name><surname>Woll</surname><given-names>PS</given-names></name><etal></etal></person-group>. <article-title>Initial seeding of the embryonic thymus by immune-restricted lympho-myeloid progenitors</article-title>. <source/>Nat Immunol. (<year>2016</year>) <volume>17</volume>:<fpage>1424</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3576</pub-id><pub-id pub-id-type="pmid">27695000</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Douarin</surname><given-names>NM</given-names></name><name><surname>Jotereau</surname><given-names>FV</given-names></name></person-group>. <article-title>Tracing of cells of the avian thymus through embryonic life in interspecific chimeras</article-title>. <source/>J Exp Med. (<year>1975</year>) <volume>142</volume>:<fpage>17</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1084/jem.142.1.17</pub-id><pub-id pub-id-type="pmid">239088</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klug</surname><given-names>DB</given-names></name><name><surname>Carter</surname><given-names>C</given-names></name><name><surname>Gimenez-Conti</surname><given-names>IB</given-names></name><name><surname>Richie</surname><given-names>ER</given-names></name></person-group>. <article-title>Cutting Edge: thymocyte-independent and thymocyte-dependent phases of epithelial patterning in the fetal thymus</article-title>. <source/>J Immunol. (<year>2002</year>) <volume>169</volume>:<fpage>2842</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.169.6.2842</pub-id><pub-id pub-id-type="pmid">12218095</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>G</given-names></name><name><surname>Takahama</surname><given-names>Y</given-names></name></person-group>. <article-title>Thymic epithelial cells: working class heroes for T cell development and repertoire selection</article-title>. <source/>Trends Immunol. (<year>2012</year>) <volume>33</volume>:<fpage>256</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2012.03.005</pub-id><pub-id pub-id-type="pmid">22591984</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaidya</surname><given-names>HJ</given-names></name><name><surname>Briones Leon</surname><given-names>A</given-names></name><name><surname>Blackburn</surname><given-names>CC</given-names></name></person-group>. <article-title>FOXN1 in thymus organogenesis and development</article-title>. <source/>Eur J Immunol. (<year>2016</year>) <volume>46</volume>:<fpage>1826</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201545814</pub-id><pub-id pub-id-type="pmid">27378598</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramson</surname><given-names>J</given-names></name><name><surname>Anderson</surname><given-names>G</given-names></name></person-group>. <article-title>Thymic epithelial cells</article-title>. <source/>Annu Rev Immunol. (<year>2017</year>) <volume>35</volume>:<fpage>85</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-051116-052320</pub-id><pub-id pub-id-type="pmid">28226225</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hikosaka</surname><given-names>Y</given-names></name><name><surname>Nitta</surname><given-names>T</given-names></name><name><surname>Ohigashi</surname><given-names>I</given-names></name><name><surname>Yano</surname><given-names>K</given-names></name><name><surname>Ishimaru</surname><given-names>N</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><etal></etal></person-group>. <article-title>The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator</article-title>. <source/>Immunity. (<year>2008</year>) <volume>29</volume>:<fpage>438</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2008.06.018</pub-id><pub-id pub-id-type="pmid">18799150</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satoh</surname><given-names>R</given-names></name><name><surname>Kakugawa</surname><given-names>K</given-names></name><name><surname>Yasuda</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Sibilia</surname><given-names>M</given-names></name><name><surname>Katsura</surname><given-names>Y</given-names></name><etal></etal></person-group>. <article-title>Requirement of Stat3 signaling in the postnatal development of thymic medullary epithelial cells</article-title>. <source/>PLoS Genet. (<year>2016</year>) <volume>12</volume>:<fpage>e5776</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1005776</pub-id><pub-id pub-id-type="pmid">26789017</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>H</given-names></name><name><surname>Chai</surname><given-names>Q</given-names></name><name><surname>Jin</surname><given-names>C</given-names></name><name><surname>Ren</surname><given-names>B</given-names></name><etal></etal></person-group>. <article-title>Epithelial LTbetaR signaling controls the population size of the progenitors of medullary thymic epithelial cells in neonatal mice</article-title>. <source/>Sci Rep. (<year>2017</year>) <volume>7</volume>:<fpage>44481</fpage>. <pub-id pub-id-type="doi">10.1038/srep44481</pub-id><pub-id pub-id-type="pmid">28290551</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SH</given-names></name><name><surname>Bae</surname><given-names>YM</given-names></name><name><surname>Kim</surname><given-names>TJ</given-names></name><name><surname>Ha</surname><given-names>IS</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Chi</surname><given-names>JG</given-names></name><etal></etal></person-group>. <article-title>HLA-DR expression in human fetal thymocytes</article-title>. <source/>Hum Immunol. (<year>1992</year>) <volume>33</volume>:<fpage>294</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/0198-8859(92)90338-n</pub-id><pub-id pub-id-type="pmid">1639632</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>EY</given-names></name><name><surname>Jung</surname><given-names>KC</given-names></name><name><surname>Park</surname><given-names>HJ</given-names></name><name><surname>Chung</surname><given-names>DH</given-names></name><name><surname>Song</surname><given-names>JS</given-names></name><name><surname>Yang</surname><given-names>SD</given-names></name><etal></etal></person-group>. <article-title>Thymocyte-thymocyte interaction for efficient positive selection and maturation of CD4 T cells</article-title>. <source/>Immunity. (<year>2005</year>) <volume>23</volume>:<fpage>387</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2005.09.005</pub-id><pub-id pub-id-type="pmid">16226504</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>MG</given-names></name><name><surname>Gourley</surname><given-names>TS</given-names></name><name><surname>Mccarthy</surname><given-names>BP</given-names></name><name><surname>Sant'angelo</surname><given-names>DB</given-names></name><name><surname>Chang</surname><given-names>CH</given-names></name></person-group>. <article-title>An alternate pathway for CD4 T cell development: thymocyte-expressed MHC class II selects a distinct T cell population</article-title>. <source/>Immunity. (<year>2005</year>) <volume>23</volume>:<fpage>375</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2005.09.002</pub-id><pub-id pub-id-type="pmid">16226503</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>L</given-names></name><name><surname>Kyewski</surname><given-names>B</given-names></name><name><surname>Allen</surname><given-names>PM</given-names></name><name><surname>Hogquist</surname><given-names>KA</given-names></name></person-group>. <article-title>Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see)</article-title>. <source/>Nat Rev Immunol. (<year>2014</year>) <volume>14</volume>:<fpage>377</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1038/nri3667</pub-id><pub-id pub-id-type="pmid">24830344</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname><given-names>K</given-names></name><name><surname>Kondo</surname><given-names>K</given-names></name><name><surname>Takahama</surname><given-names>Y</given-names></name></person-group>. <article-title>Generation of peptides that promote positive selection in the thymus</article-title>. <source/>J Immunol. (<year>2017</year>) <volume>198</volume>:<fpage>2215</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1601862</pub-id><pub-id pub-id-type="pmid">28264997</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrow</surname><given-names>BE</given-names></name><name><surname>Mcdonald-Mcginn</surname><given-names>DM</given-names></name><name><surname>Emanuel</surname><given-names>BS</given-names></name><name><surname>Vermeesch</surname><given-names>JR</given-names></name><name><surname>Scambler</surname><given-names>PJ</given-names></name></person-group>. <article-title>Molecular genetics of 22q11.2 deletion syndrome</article-title>. <source/>Am J Med Genet A. (<year>2018</year>) <volume>176</volume>:<fpage>2070</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.40504</pub-id><pub-id pub-id-type="pmid">30380194</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>KE</given-names></name></person-group>. <article-title>Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome</article-title>. <source/>Immunol Rev. (<year>2019</year>) <volume>287</volume>:<fpage>186</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1111/imr.12701</pub-id><pub-id pub-id-type="pmid">30565249</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zinkstok</surname><given-names>JR</given-names></name><name><surname>Boot</surname><given-names>E</given-names></name><name><surname>Bassett</surname><given-names>AS</given-names></name><name><surname>Hiroi</surname><given-names>N</given-names></name><name><surname>Butcher</surname><given-names>NJ</given-names></name><name><surname>Vingerhoets</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>Neurobiological perspective of 22q11.2 deletion syndrome</article-title>. <source/>Lancet Psychiatry. (<year>2019</year>) <volume>6</volume>:<fpage>951</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/S2215-0366(19)30076-8</pub-id><pub-id pub-id-type="pmid">31395526</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mcdonald-Mcginn</surname><given-names>DM</given-names></name><name><surname>Sullivan</surname><given-names>KE</given-names></name><name><surname>Marino</surname><given-names>B</given-names></name><name><surname>Philip</surname><given-names>N</given-names></name><name><surname>Swillen</surname><given-names>A</given-names></name><name><surname>Vorstman</surname><given-names>JA</given-names></name><etal></etal></person-group>. <article-title>22q11.2 deletion syndrome</article-title>. <source/>Nat Rev Dis Primers. (<year>2015</year>) <volume>1</volume>:<fpage>15071</fpage>. <pub-id pub-id-type="doi">10.1038/nrdp.2015.71</pub-id><pub-id pub-id-type="pmid">27189754</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merico</surname><given-names>D</given-names></name><name><surname>Costain</surname><given-names>G</given-names></name><name><surname>Butcher</surname><given-names>NJ</given-names></name><name><surname>Warnica</surname><given-names>W</given-names></name><name><surname>Ogura</surname><given-names>L</given-names></name><name><surname>Alfred</surname><given-names>SE</given-names></name><etal></etal></person-group>. <article-title>MicroRNA dysregulation, gene networks, and risk for schizophrenia in 22q11.2 deletion syndrome</article-title>. <source/>Front Neurol. (<year>2014</year>) <volume>5</volume>:<fpage>238</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2014.00238</pub-id><pub-id pub-id-type="pmid">25484875</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guna</surname><given-names>A</given-names></name><name><surname>Butcher</surname><given-names>NJ</given-names></name><name><surname>Bassett</surname><given-names>AS</given-names></name></person-group>. <article-title>Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms</article-title>. <source/>J Neurodev Disord. (<year>2015</year>) <volume>7</volume>:<fpage>18</fpage>. <pub-id pub-id-type="doi">10.1186/s11689-015-9113-x</pub-id><pub-id pub-id-type="pmid">26137170</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meechan</surname><given-names>DW</given-names></name><name><surname>Maynard</surname><given-names>TM</given-names></name><name><surname>Tucker</surname><given-names>ES</given-names></name><name><surname>Fernandez</surname><given-names>A</given-names></name><name><surname>Karpinski</surname><given-names>BA</given-names></name><name><surname>Rothblat</surname><given-names>LA</given-names></name><etal></etal></person-group>. <article-title>Modeling a model: mouse genetics, 22q11.2 deletion syndrome, and disorders of cortical circuit development</article-title>. <source/>Prog Neurobiol. (<year>2015</year>) <volume>130</volume>:<fpage>1</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2015.03.004</pub-id><pub-id pub-id-type="pmid">25866365</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botto</surname><given-names>LD</given-names></name><name><surname>May</surname><given-names>K</given-names></name><name><surname>Fernhoff</surname><given-names>PM</given-names></name><name><surname>Correa</surname><given-names>A</given-names></name><name><surname>Coleman</surname><given-names>K</given-names></name><name><surname>Rasmussen</surname><given-names>SA</given-names></name><etal></etal></person-group>. <article-title>A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population</article-title>. <source/>Pediatrics. (<year>2003</year>) <volume>112</volume>:<fpage>101</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1542/peds.112.1.101</pub-id><pub-id pub-id-type="pmid">12837874</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oskarsdottir</surname><given-names>S</given-names></name><name><surname>Vujic</surname><given-names>M</given-names></name><name><surname>Fasth</surname><given-names>A</given-names></name></person-group>. <article-title>Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden</article-title>. <source/>Arch Dis Child. (<year>2004</year>) <volume>89</volume>:<fpage>148</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1136/adc.2003.026880</pub-id><pub-id pub-id-type="pmid">14736631</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>KE</given-names></name></person-group>. <article-title>The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome</article-title>. <source/>Curr Opin Allergy Clin Immunol.
<volume>4</volume>:<fpage>505</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1097/00130832-200412000-00006</pub-id><pub-id pub-id-type="pmid">15640691</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douek</surname><given-names>DC</given-names></name><name><surname>Mcfarland</surname><given-names>RD</given-names></name><name><surname>Keiser</surname><given-names>PH</given-names></name><name><surname>Gage</surname><given-names>EA</given-names></name><name><surname>Massey</surname><given-names>JM</given-names></name><name><surname>Haynes</surname><given-names>BF</given-names></name><etal></etal></person-group>. <article-title>Changes in thymic function with age and during the treatment of HIV infection</article-title>. <source/>Nature. (<year>1998</year>) <volume>396</volume>:<fpage>690</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/25374</pub-id><pub-id pub-id-type="pmid">9872319</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrando-Martínez</surname><given-names>S</given-names></name><name><surname>Lorente</surname><given-names>R</given-names></name><name><surname>Gurbindo</surname><given-names>D</given-names></name><name><surname>José</surname><given-names>M</given-names></name><name><surname>Leal</surname><given-names>M</given-names></name><name><surname>Muñoz-Fernández</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Low thymic output, peripheral homeostasis deregulation, and hastened regulatory T cells differentiation in children with 22q11.2 deletion syndrome</article-title>. <source/>J Pediatrics. (<year>2014</year>) <volume>164</volume>:<fpage>882</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2013.12.013</pub-id><pub-id pub-id-type="pmid">24461789</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markert</surname><given-names>ML</given-names></name><name><surname>Boeck</surname><given-names>A</given-names></name><name><surname>Hale</surname><given-names>LP</given-names></name><name><surname>Kloster</surname><given-names>AL</given-names></name><name><surname>Mclaughlin</surname><given-names>TM</given-names></name><name><surname>Batchvarova</surname><given-names>MN</given-names></name><etal></etal></person-group>. <article-title>Transplantation of thymus tissue in complete DiGeorge syndrome</article-title>. <source/>N Engl J Med. (<year>1999</year>) <volume>341</volume>:<fpage>1180</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM199910143411603</pub-id><pub-id pub-id-type="pmid">10523153</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markert</surname><given-names>ML</given-names></name><name><surname>Sarzotti</surname><given-names>M</given-names></name><name><surname>Ozaki</surname><given-names>DA</given-names></name><name><surname>Sempowski</surname><given-names>GD</given-names></name><name><surname>Rhein</surname><given-names>ME</given-names></name><name><surname>Hale</surname><given-names>LP</given-names></name><etal></etal></person-group>. <article-title>Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients</article-title>. <source/>Blood. (<year>2003</year>) <volume>102</volume>:<fpage>1121</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2002-08-2545</pub-id><pub-id pub-id-type="pmid">12702512</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinn</surname><given-names>IK</given-names></name><name><surname>Milner</surname><given-names>JD</given-names></name><name><surname>Scheinberg</surname><given-names>P</given-names></name><name><surname>Douek</surname><given-names>DC</given-names></name><name><surname>Markert</surname><given-names>ML</given-names></name></person-group>. <article-title>Thymus transplantation restores the repertoires of forkhead box protein 3 (FoxP3)+ and FoxP3- T cells in complete DiGeorge anomaly</article-title>. <source/>Clin Exp Immunol. (<year>2013</year>) <volume>173</volume>:<fpage>140</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/cei.12088</pub-id><pub-id pub-id-type="pmid">23607606</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>EG</given-names></name></person-group>. <article-title>Immunodeficiency in DiGeorge syndrome and options for treating cases with complete athymia</article-title>. <source/>Front Immunol. (<year>2013</year>) <volume>4</volume>:<fpage>322</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2013.00322</pub-id><pub-id pub-id-type="pmid">24198816</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kernfeld</surname><given-names>EM</given-names></name><name><surname>Genga</surname><given-names>RMJ</given-names></name><name><surname>Neherin</surname><given-names>K</given-names></name><name><surname>Magaletta</surname><given-names>ME</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Maehr</surname><given-names>R</given-names></name></person-group>. <article-title>A single-cell transcriptomic atlas of thymus organogenesis resolves cell types and developmental maturation</article-title>. <source/>Immunity. (<year>2018</year>) <volume>48</volume>:<fpage>1258</fpage>–<lpage>70.e1256</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2018.04.015</pub-id><pub-id pub-id-type="pmid">29884461</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markert</surname><given-names>ML</given-names></name><name><surname>Devlin</surname><given-names>BH</given-names></name><name><surname>Alexieff</surname><given-names>MJ</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Mccarthy</surname><given-names>EA</given-names></name><name><surname>Gupton</surname><given-names>SE</given-names></name><etal></etal></person-group>. <article-title>Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants</article-title>. <source/>Blood. (<year>2007</year>) <volume>109</volume>:<fpage>4539</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2006-10-048652</pub-id><pub-id pub-id-type="pmid">17284531</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markert</surname><given-names>ML</given-names></name><name><surname>Devlin</surname><given-names>BH</given-names></name><name><surname>Mccarthy</surname><given-names>EA</given-names></name></person-group>. <article-title>Thymus transplantation</article-title>. <source/>Clin Immunol. (<year>2010</year>) <volume>135</volume>:<fpage>236</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.clim.2010.02.007</pub-id><pub-id pub-id-type="pmid">20236866</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takaki</surname><given-names>T</given-names></name><name><surname>Hosaka</surname><given-names>N</given-names></name><name><surname>Miyake</surname><given-names>T</given-names></name><name><surname>Cui</surname><given-names>W</given-names></name><name><surname>Nishida</surname><given-names>T</given-names></name><name><surname>Inaba</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Presence of donor-derived thymic epithelial cells in [B6 → MRL/lpr] mice after allogeneic intra-bone marrow–bone marrow transplantation (IBM–BMT)</article-title>. <source/>J Autoimmunity. (<year>2008</year>) <volume>31</volume>:<fpage>408</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaut.2008.09.003</pub-id><pub-id pub-id-type="pmid">19022623</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Jeon</surname><given-names>YK</given-names></name><name><surname>Kang</surname><given-names>BH</given-names></name><name><surname>Chung</surname><given-names>DH</given-names></name><name><surname>Park</surname><given-names>CG</given-names></name><name><surname>Shin</surname><given-names>HY</given-names></name><etal></etal></person-group>. <article-title>Generation of PLZF+ CD4+ T cells via MHC class II-dependent thymocyte-thymocyte interaction is a physiological process in humans</article-title>. <source/>J Exp Med. (<year>2010</year>) <volume>207</volume>:<fpage>237</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20091519</pub-id><pub-id pub-id-type="pmid">20038602</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinn</surname><given-names>IK</given-names></name><name><surname>Markert</surname><given-names>ML</given-names></name></person-group>. <article-title>Induction of tolerance to parental parathyroid grafts using allogeneic thymus tissue in patients with DiGeorge anomaly</article-title>. <source/>J Allergy Clin Immunol. (<year>2011</year>) <volume>127</volume>:<fpage>1351</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2011.03.033</pub-id><pub-id pub-id-type="pmid">21513969</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janda</surname><given-names>A</given-names></name><name><surname>Sedlacek</surname><given-names>P</given-names></name><name><surname>Hönig</surname><given-names>M</given-names></name><name><surname>Friedrich</surname><given-names>W</given-names></name><name><surname>Champagne</surname><given-names>M</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name><etal></etal></person-group>. <article-title>Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly</article-title>. <source/>Blood. (<year>2010</year>) <volume>116</volume>:<fpage>2229</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2010-03-275966</pub-id><pub-id pub-id-type="pmid">20530285</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojima</surname><given-names>D</given-names></name><name><surname>Muramatsu</surname><given-names>H</given-names></name><name><surname>Okuno</surname><given-names>Y</given-names></name><name><surname>Kataoka</surname><given-names>S</given-names></name><name><surname>Murakami</surname><given-names>N</given-names></name><name><surname>Tanahashi</surname><given-names>Y</given-names></name><etal></etal></person-group>. <article-title>Successful T-cell reconstitution after unrelated cord blood transplantation in a patient with complete DiGeorge syndrome</article-title>. <source/>J Allergy Clin Immunol. (<year>2016</year>) <volume>138</volume>:<fpage>1471</fpage>–<lpage>3.e1474</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2016.04.048</pub-id><pub-id pub-id-type="pmid">27444175</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldsobel</surname><given-names>AB</given-names></name><name><surname>Haas</surname><given-names>A</given-names></name><name><surname>Stiehm</surname><given-names>ER</given-names></name></person-group>. <article-title>Bone marrow transplantation in DiGeorge syndrome</article-title>. <source/>J Pediatr. (<year>1987</year>) <volume>111</volume>:<fpage>40</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-3476(87)80339-6</pub-id><pub-id pub-id-type="pmid">3298595</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Amamoto</surname><given-names>N</given-names></name><name><surname>Kondoh</surname><given-names>T</given-names></name><name><surname>Nakayama</surname><given-names>M</given-names></name><name><surname>Takayanagi</surname><given-names>T</given-names></name><name><surname>Tsuji</surname><given-names>Y</given-names></name></person-group>. <article-title>Complete-type DiGeorge syndrome treated by bone marrow transplantation</article-title>. <source/>Bone Marrow Transpl. (<year>1998</year>) <volume>22</volume>:<fpage>927</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bmt.1701475</pub-id><pub-id pub-id-type="pmid">9827824</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Land</surname><given-names>MH</given-names></name><name><surname>Garcia-Lloret</surname><given-names>MI</given-names></name><name><surname>Borzy</surname><given-names>MS</given-names></name><name><surname>Rao</surname><given-names>PN</given-names></name><name><surname>Aziz</surname><given-names>N</given-names></name><name><surname>Mcghee</surname><given-names>SA</given-names></name><etal></etal></person-group>. <article-title>Long-term results of bone marrow transplantation in complete DiGeorge syndrome</article-title>. <source/>J Allergy Clin Immunol. (<year>2007</year>) <volume>120</volume>:<fpage>908</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2007.08.048</pub-id><pub-id pub-id-type="pmid">17931564</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markert</surname><given-names>ML</given-names></name></person-group>. <article-title>Treatment of infants with complete DiGeorge anomaly</article-title>. <source/>J Allergy Clin Immunol. (<year>2008</year>) <volume>121</volume>:<fpage>1063</fpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2007.12.1181</pub-id><pub-id pub-id-type="pmid">18289653</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcovecchio</surname><given-names>GE</given-names></name><name><surname>Bortolomai</surname><given-names>I</given-names></name><name><surname>Ferrua</surname><given-names>F</given-names></name><name><surname>Fontana</surname><given-names>E</given-names></name><name><surname>Imberti</surname><given-names>L</given-names></name><name><surname>Conforti</surname><given-names>E</given-names></name><etal></etal></person-group>. <article-title>Thymic epithelium abnormalities in DiGeorge and down syndrome patients contribute to dysregulation in T cell development</article-title>. <source/>Front Immunol. (<year>2019</year>) <volume>10</volume>:<fpage>447</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00447</pub-id><pub-id pub-id-type="pmid">30949166</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montin</surname><given-names>D</given-names></name><name><surname>Marolda</surname><given-names>A</given-names></name><name><surname>Licciardi</surname><given-names>F</given-names></name><name><surname>Robasto</surname><given-names>F</given-names></name><name><surname>Di Cesare</surname><given-names>S</given-names></name><name><surname>Ricotti</surname><given-names>E</given-names></name><etal></etal></person-group>. <article-title>Immunophenotype anomalies predict the development of autoimmune cytopenia in 22q11.2 deletion syndrome</article-title>. <source/>J Allergy Clin Immunol. (<year>2019</year>) <volume>7</volume>:<fpage>2369</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaip.2019.03.014</pub-id><pub-id pub-id-type="pmid">30922987</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mcdonald-Mcginn</surname><given-names>DM</given-names></name><name><surname>Reilly</surname><given-names>A</given-names></name><name><surname>Wallgren-Pettersson</surname><given-names>C</given-names></name><name><surname>Hoyme</surname><given-names>HE</given-names></name><name><surname>Yang</surname><given-names>SP</given-names></name><name><surname>Adam</surname><given-names>MP</given-names></name><etal></etal></person-group>. <article-title>Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)</article-title>. <source/>Am J Med Genet A. (<year>2006</year>) <volume>140</volume>:<fpage>906</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31199</pub-id><pub-id pub-id-type="pmid">16532473</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piliero</surname><given-names>LM</given-names></name><name><surname>Sanford</surname><given-names>AN</given-names></name><name><surname>Mcdonald-Mcginn</surname><given-names>DM</given-names></name><name><surname>Zackai</surname><given-names>EH</given-names></name><name><surname>Sullivan</surname><given-names>KE</given-names></name></person-group>. <article-title>T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome</article-title>. <source/>Blood. (<year>2004</year>) <volume>103</volume>:<fpage>1020</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2003-08-2824</pub-id><pub-id pub-id-type="pmid">14525774</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staple</surname><given-names>L</given-names></name><name><surname>Andrews</surname><given-names>T</given-names></name><name><surname>Mcdonald-Mcginn</surname><given-names>D</given-names></name><name><surname>Zackai</surname><given-names>E</given-names></name><name><surname>Sullivan</surname><given-names>KE</given-names></name></person-group>. <article-title>Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) and patients with chronic granulomatous disease</article-title>. <source/>Pediatr Allergy Immunol. (<year>2005</year>) <volume>16</volume>:<fpage>226</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-3038.2005.00259.x</pub-id><pub-id pub-id-type="pmid">15853951</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanaya</surname><given-names>Y</given-names></name><name><surname>Ohga</surname><given-names>S</given-names></name><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Furuno</surname><given-names>K</given-names></name><name><surname>Ohno</surname><given-names>T</given-names></name><name><surname>Takada</surname><given-names>H</given-names></name><etal></etal></person-group>. <article-title>Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome</article-title>. <source/>Clin Exp Immunol. (<year>2006</year>) <volume>144</volume>:<fpage>85</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2006.03038.x</pub-id><pub-id pub-id-type="pmid">16542369</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zemble</surname><given-names>R</given-names></name><name><surname>Luning Prak</surname><given-names>E</given-names></name><name><surname>Mcdonald</surname><given-names>K</given-names></name><name><surname>Mcdonald-Mcginn</surname><given-names>D</given-names></name><name><surname>Zackai</surname><given-names>E</given-names></name><name><surname>Sullivan</surname><given-names>K</given-names></name></person-group>. <article-title>Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)</article-title>. <source/>Clin Immunol. (<year>2010</year>) <volume>136</volume>:<fpage>409</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.clim.2010.04.011</pub-id><pub-id pub-id-type="pmid">20472505</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindsay</surname><given-names>EA</given-names></name><name><surname>Botta</surname><given-names>A</given-names></name><name><surname>Jurecic</surname><given-names>V</given-names></name><name><surname>Carattini-Rivera</surname><given-names>S</given-names></name><name><surname>Cheah</surname><given-names>YC</given-names></name><name><surname>Rosenblatt</surname><given-names>HM</given-names></name><etal></etal></person-group>. <article-title>Congenital heart disease in mice deficient for the DiGeorge syndrome region</article-title>. <source/>Nature. (<year>1999</year>) <volume>401</volume>:<fpage>379</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1038/43900</pub-id><pub-id pub-id-type="pmid">10517636</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merscher</surname><given-names>S</given-names></name><name><surname>Funke</surname><given-names>B</given-names></name><name><surname>Epstein</surname><given-names>JA</given-names></name><name><surname>Heyer</surname><given-names>J</given-names></name><name><surname>Puech</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>MM</given-names></name><etal></etal></person-group>. <article-title>TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome</article-title>. <source/>Cell. (<year>2001</year>) <volume>104</volume>:<fpage>619</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(01)00247-1</pub-id><pub-id pub-id-type="pmid">11239417</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Digeorge</surname><given-names>A</given-names></name></person-group>
<article-title>Congenital Absence of the thymus and its immunological consequences: concurrence with congenital hypoparathyroidism</article-title>. <source/>Birth Defects Orig ArtSerIV. (<year>1968</year>) <volume>1</volume>:<fpage>116</fpage>–<lpage>21</lpage>.</mixed-citation>
</ref>
<ref id="B93">
<label>93.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puech</surname><given-names>A</given-names></name><name><surname>Saint-Jore</surname><given-names>B</given-names></name><name><surname>Merscher</surname><given-names>S</given-names></name><name><surname>Russell</surname><given-names>RG</given-names></name><name><surname>Cherif</surname><given-names>D</given-names></name><name><surname>Sirotkin</surname><given-names>H</given-names></name><etal></etal></person-group>. <article-title>Normal cardiovascular development in mice deficient for 16 genes in 550 kb of the velocardiofacial/DiGeorge syndrome region</article-title>. <source/>Proc Natl Acad Sci USA. (<year>2000</year>) <volume>97</volume>:<fpage>10090</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.97.18.10090</pub-id><pub-id pub-id-type="pmid">10963672</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindsay</surname><given-names>EA</given-names></name><name><surname>Vitelli</surname><given-names>F</given-names></name><name><surname>Su</surname><given-names>H</given-names></name><name><surname>Morishima</surname><given-names>M</given-names></name><name><surname>Huynh</surname><given-names>T</given-names></name><name><surname>Pramparo</surname><given-names>T</given-names></name><etal></etal></person-group>. <article-title>Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice</article-title>. <source/>Nature. (<year>2001</year>) <volume>410</volume>:<fpage>97</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1038/35065105</pub-id><pub-id pub-id-type="pmid">11242049</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>J</given-names></name><name><surname>Kochilas</surname><given-names>L</given-names></name><name><surname>Nowotschin</surname><given-names>S</given-names></name><name><surname>Arnold</surname><given-names>JS</given-names></name><name><surname>Aggarwal</surname><given-names>VS</given-names></name><name><surname>Epstein</surname><given-names>JA</given-names></name><etal></etal></person-group>. <article-title>Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage</article-title>. <source/>Hum Mol Genet. (<year>2004</year>) <volume>13</volume>:<fpage>1577</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddh176</pub-id><pub-id pub-id-type="pmid">15190012</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jerome</surname><given-names>LA</given-names></name><name><surname>Papaioannou</surname><given-names>VE</given-names></name></person-group>. <article-title>DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1</article-title>. <source/>Nat Genet. (<year>2001</year>) <volume>27</volume>:<fpage>286</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1038/85845</pub-id><pub-id pub-id-type="pmid">11242110</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulcoli</surname><given-names>FG</given-names></name><name><surname>Franzese</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Angelini</surname><given-names>C</given-names></name><name><surname>Baldini</surname><given-names>A</given-names></name></person-group>. <article-title>Rebalancing gene haploinsufficiency <italic>in vivo</italic> by targeting chromatin</article-title>. <source/>Nat Commun. (<year>2016</year>) <volume>7</volume>:<fpage>11688</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms11688</pub-id><pub-id pub-id-type="pmid">27256596</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Diacou</surname><given-names>A</given-names></name><name><surname>Johnston</surname><given-names>HR</given-names></name><name><surname>Musfee</surname><given-names>FI</given-names></name><name><surname>Mcdonald-Mcginn</surname><given-names>DM</given-names></name><name><surname>Mcginn</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>Complete sequence of the 22q11.2 allele in 1,053 subjects with 22q11.2 deletion syndrome reveals modifiers of conotruncal heart defects</article-title>. <source/>Am J Hum Genet. (<year>2020</year>) <volume>106</volume>:<fpage>26</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2019.11.010</pub-id><pub-id pub-id-type="pmid">31870554</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De La Morena</surname><given-names>MT</given-names></name><name><surname>Eitson</surname><given-names>JL</given-names></name><name><surname>Dozmorov</surname><given-names>IM</given-names></name><name><surname>Belkaya</surname><given-names>S</given-names></name><name><surname>Hoover</surname><given-names>AR</given-names></name><name><surname>Anguiano</surname><given-names>E</given-names></name><etal></etal></person-group>. <article-title>Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome</article-title>. <source/>Clin Immunol. (<year>2013</year>) <volume>147</volume>:<fpage>11</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.clim.2013.01.011</pub-id><pub-id pub-id-type="pmid">23454892</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimber</surname><given-names>WL</given-names></name><name><surname>Hsieh</surname><given-names>P</given-names></name><name><surname>Hirotsune</surname><given-names>S</given-names></name><name><surname>Yuva-Paylor</surname><given-names>L</given-names></name><name><surname>Sutherland</surname><given-names>HF</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Deletion of 150 kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse</article-title>. <source/>Hum Mol Genet. (<year>1999</year>) <volume>8</volume>:<fpage>2229</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/8.12.2229</pub-id><pub-id pub-id-type="pmid">10545603</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Baldini</surname><given-names>A</given-names></name></person-group>. <article-title><italic>In vivo</italic> response to high-resolution variation of Tbx1 mRNA dosage</article-title>. <source/>Hum Mol Genet. (<year>2008</year>) <volume>17</volume>:<fpage>150</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddm291</pub-id><pub-id pub-id-type="pmid">17916582</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindsay</surname><given-names>EA</given-names></name><name><surname>Baldini</surname><given-names>A</given-names></name></person-group>. <article-title>Recovery from arterial growth delay reduces penetrance of cardiovascular defects in mice deleted for the DiGeorge syndrome region</article-title>. <source/>Hum Mol Genet. (<year>2001</year>) <volume>10</volume>:<fpage>997</fpage>–<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/10.9.997</pub-id><pub-id pub-id-type="pmid">11309372</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reeh</surname><given-names>KA</given-names></name><name><surname>Cardenas</surname><given-names>KT</given-names></name><name><surname>Bain</surname><given-names>VE</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Laurent</surname><given-names>M</given-names></name><name><surname>Manley</surname><given-names>NR</given-names></name><etal></etal></person-group>. <article-title>Ectopic TBX1 suppresses thymic epithelial cell differentiation and proliferation during thymus organogenesis</article-title>. <source/>Development. (<year>2014</year>) <volume>141</volume>:<fpage>2950</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1242/dev.111641</pub-id><pub-id pub-id-type="pmid">25053428</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfano</surname><given-names>D</given-names></name><name><surname>Altomonte</surname><given-names>A</given-names></name><name><surname>Cortes</surname><given-names>C</given-names></name><name><surname>Bilio</surname><given-names>M</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name><name><surname>Baldini</surname><given-names>A</given-names></name></person-group>. <article-title>Tbx1 regulates extracellular matrix-cell interactions in the second heart field</article-title>. <source/>Hum Mol Genet. (<year>2019</year>) <volume>28</volume>:<fpage>2295</fpage>–<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddz058</pub-id><pub-id pub-id-type="pmid">31180501</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergman</surname><given-names>JE</given-names></name><name><surname>Janssen</surname><given-names>N</given-names></name><name><surname>Van Der Sloot</surname><given-names>AM</given-names></name><name><surname>De Walle</surname><given-names>HE</given-names></name><name><surname>Schoots</surname><given-names>J</given-names></name><name><surname>Rendtorff</surname><given-names>ND</given-names></name><etal></etal></person-group>. <article-title>A novel classification system to predict the pathogenic effects of CHD7 missense variants in CHARGE syndrome</article-title>. <source/>Hum Mutat. (<year>2012</year>) <volume>33</volume>:<fpage>1251</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22106</pub-id><pub-id pub-id-type="pmid">22539353</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>MTY</given-names></name><name><surname>Schölvinck</surname><given-names>EH</given-names></name><name><surname>Lambeck</surname><given-names>AJA</given-names></name><name><surname>Van Ravenswaaij-Arts</surname><given-names>CMA</given-names></name></person-group>. <article-title>CHARGE syndrome: a review of the immunological aspects</article-title>. <source/>Eur J Hum Genet. (<year>2015</year>) <volume>23</volume>:<fpage>1451</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2015.7</pub-id><pub-id pub-id-type="pmid">25689927</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Ravenswaaij-Arts</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>DM</given-names></name></person-group>. <article-title>New insights and advances in CHARGE syndrome: diagnosis, etiologies, treatments, and research discoveries</article-title>. <source/>Am J Med Genet C. (<year>2017</year>) <volume>175</volume>:<fpage>397</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.c.31592</pub-id><pub-id pub-id-type="pmid">29171162</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouazoune</surname><given-names>K</given-names></name><name><surname>Kingston</surname><given-names>RE</given-names></name></person-group>. <article-title>Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disorders</article-title>. <source/>Proc Natl Acad Sci USA. (<year>2012</year>) <volume>109</volume>:<fpage>19238</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1213825109</pub-id><pub-id pub-id-type="pmid">23134727</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zentner</surname><given-names>GE</given-names></name><name><surname>Hurd</surname><given-names>EA</given-names></name><name><surname>Schnetz</surname><given-names>MP</given-names></name><name><surname>Handoko</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><etal></etal></person-group>. <article-title>CHD7 functions in the nucleolus as a positive regulator of ribosomal RNA biogenesis</article-title>. <source/>Hum Mol Genet. (<year>2010</year>) <volume>19</volume>:<fpage>3491</fpage>–<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddq265</pub-id><pub-id pub-id-type="pmid">20591827</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zentner</surname><given-names>GE</given-names></name><name><surname>Layman</surname><given-names>WS</given-names></name><name><surname>Martin</surname><given-names>DM</given-names></name><name><surname>Scacheri</surname><given-names>PC</given-names></name></person-group>. <article-title>Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome</article-title>. <source/>Am J Med Genet A. (<year>2010</year>) <volume>152A</volume>:<fpage>674</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.33323</pub-id><pub-id pub-id-type="pmid">20186815</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jyonouchi</surname><given-names>S</given-names></name><name><surname>Mcdonald-Mcginn</surname><given-names>DM</given-names></name><name><surname>Bale</surname><given-names>S</given-names></name><name><surname>Zackai</surname><given-names>EH</given-names></name><name><surname>Sullivan</surname><given-names>KE</given-names></name></person-group>
<article-title>CHARGE (Coloboma, Heart Defect, Atresia Choanae, Retarded Growth and Development, Genital Hypoplasia, Ear Anomalies/Deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and non-immunologic phenotypic features</article-title>. <source/>Pediatrics. (<year>2009</year>) <volume>123</volume>:<fpage>e871</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2008-3400</pub-id><pub-id pub-id-type="pmid">19403480</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>MTY</given-names></name><name><surname>Lambeck</surname><given-names>AJA</given-names></name><name><surname>Van Der Burg</surname><given-names>M</given-names></name><name><surname>La Bastide-Van Gemert</surname><given-names>S</given-names></name><name><surname>Hogendorf</surname><given-names>LA</given-names></name><name><surname>Van Ravenswaaij-Arts</surname><given-names>CMA</given-names></name><etal></etal></person-group>. <article-title>Immune dysfunction in children with CHARGE syndrome: a cross-sectional study</article-title>. <source/>PLoS ONE. (<year>2015</year>) <volume>10</volume>:<fpage>e0142350</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0142350</pub-id><pub-id pub-id-type="pmid">26544072</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanlaville</surname><given-names>D</given-names></name><name><surname>Etchevers</surname><given-names>HC</given-names></name><name><surname>Gonzales</surname><given-names>M</given-names></name><name><surname>Martinovic</surname><given-names>J</given-names></name><name><surname>Clément-Ziza</surname><given-names>M</given-names></name><name><surname>Delezoide</surname><given-names>A-L</given-names></name><etal></etal></person-group>. <article-title>Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development</article-title>. <source/>J Med Genet. (<year>2006</year>) <volume>43</volume>:<fpage>211</fpage>–<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2005.036160</pub-id><pub-id pub-id-type="pmid">16169932</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bajpai</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>DA</given-names></name><name><surname>Rada-Iglesias</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Helms</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>CHD7 cooperates with PBAF to control multipotent neural crest formation</article-title>. <source/>Nature. (<year>2010</year>) <volume>463</volume>:<fpage>958</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1038/nature08733</pub-id><pub-id pub-id-type="pmid">20130577</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosman</surname><given-names>EA</given-names></name><name><surname>Penn</surname><given-names>AC</given-names></name><name><surname>Ambrose</surname><given-names>JC</given-names></name><name><surname>Kettleborough</surname><given-names>R</given-names></name><name><surname>Stemple</surname><given-names>DL</given-names></name><name><surname>Steel</surname><given-names>KP</given-names></name></person-group>. <article-title>Multiple mutations in mouse Chd7 provide models for CHARGE syndrome</article-title>. <source/>Hum Mol Genet. (<year>2005</year>) <volume>14</volume>:<fpage>3463</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddi375</pub-id><pub-id pub-id-type="pmid">16207732</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurd</surname><given-names>EA</given-names></name><name><surname>Poucher</surname><given-names>HK</given-names></name><name><surname>Cheng</surname><given-names>K</given-names></name><name><surname>Raphael</surname><given-names>Y</given-names></name><name><surname>Martin</surname><given-names>DM</given-names></name></person-group>. <article-title>The ATP-dependent chromatin remodeling enzyme CHD7 regulates pro-neural gene expression and neurogenesis in the inner ear</article-title>. <source/>Development. (<year>2010</year>) <volume>137</volume>:<fpage>3139</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1242/dev.047894</pub-id><pub-id pub-id-type="pmid">20736290</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogier</surname><given-names>JM</given-names></name><name><surname>Carpinelli</surname><given-names>MR</given-names></name><name><surname>Arhatari</surname><given-names>BD</given-names></name><name><surname>Symons</surname><given-names>RCA</given-names></name><name><surname>Kile</surname><given-names>BT</given-names></name><name><surname>Burt</surname><given-names>RA</given-names></name></person-group>
<article-title>CHD7 deficiency in “looper,” a new mouse model of CHARGE syndrome, results in ossicle malformation, otosclerosis and hearing impairment</article-title>. <source/>PLoS ONE. (<year>2014</year>) <volume>9</volume>:<fpage>e97559</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0097559</pub-id><pub-id pub-id-type="pmid">24840056</pub-id></mixed-citation>
</ref>
<ref id="B118">
<label>118.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gage</surname><given-names>PJ</given-names></name><name><surname>Hurd</surname><given-names>EA</given-names></name><name><surname>Martin</surname><given-names>DM</given-names></name></person-group>. <article-title>Mouse models for the dissection of CHD7 functions in eye development and the molecular basis for ocular defects in CHARGE syndrome</article-title>. <source/>Invest Ophthalmol Vis Sci. (<year>2015</year>) <volume>56</volume>:<fpage>7923</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.15-18069</pub-id><pub-id pub-id-type="pmid">26670829</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randall</surname><given-names>V</given-names></name><name><surname>Mccue</surname><given-names>K</given-names></name><name><surname>Roberts</surname><given-names>C</given-names></name><name><surname>Kyriakopoulou</surname><given-names>V</given-names></name><name><surname>Beddow</surname><given-names>S</given-names></name><name><surname>Barrett</surname><given-names>AN</given-names></name><etal></etal></person-group>. <article-title>Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice</article-title>. <source/>J Clin Invest. (<year>2009</year>) <volume>119</volume>:<fpage>3301</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1172/JCI37561</pub-id><pub-id pub-id-type="pmid">19855134</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Micucci</surname><given-names>JA</given-names></name><name><surname>Layman</surname><given-names>WS</given-names></name><name><surname>Hurd</surname><given-names>EA</given-names></name><name><surname>Sperry</surname><given-names>ED</given-names></name><name><surname>Frank</surname><given-names>SF</given-names></name><name><surname>Durham</surname><given-names>MA</given-names></name><etal></etal></person-group>. <article-title>CHD7 and retinoic acid signaling cooperate to regulate neural stem cell and inner ear development in mouse models of CHARGE syndrome</article-title>. <source/>Hum Mol Genet. (<year>2013</year>) <volume>23</volume>:<fpage>434</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt435</pub-id><pub-id pub-id-type="pmid">24026680</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>Hill</surname><given-names>SF</given-names></name><name><surname>Skidmore</surname><given-names>JM</given-names></name><name><surname>Sperry</surname><given-names>ED</given-names></name><name><surname>Swiderski</surname><given-names>DL</given-names></name><name><surname>Sanchez</surname><given-names>GJ</given-names></name><etal></etal></person-group>. <article-title>CHD7 represses the retinoic acid synthesis enzyme ALDH1A3 during inner ear development</article-title>. <source/>JCI Insight. (<year>2018</year>) <volume>3</volume>:<fpage>e97440</fpage>. <pub-id pub-id-type="doi">10.1172/jci.insight.97440</pub-id><pub-id pub-id-type="pmid">29467333</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z-Z</given-names></name><name><surname>Wang</surname><given-names>Z-L</given-names></name><name><surname>Choi</surname><given-names>T-I</given-names></name><name><surname>Huang</surname><given-names>W-T</given-names></name><name><surname>Wang</surname><given-names>H-T</given-names></name><name><surname>Han</surname><given-names>Y-Y</given-names></name><etal></etal></person-group>. <article-title>Chd7 is critical for early T-cell development and thymus organogenesis in zebrafish</article-title>. <source/>Am J Pathol. (<year>2018</year>) <volume>188</volume>:<fpage>1043</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2017.12.005</pub-id><pub-id pub-id-type="pmid">29353058</pub-id></mixed-citation>
</ref>
<ref id="B123">
<label>123.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pignata</surname><given-names>C</given-names></name><name><surname>Fiore</surname><given-names>M</given-names></name><name><surname>Guzzetta</surname><given-names>V</given-names></name><name><surname>Castaldo</surname><given-names>A</given-names></name><name><surname>Sebastio</surname><given-names>G</given-names></name><name><surname>Porta</surname><given-names>F</given-names></name><etal></etal></person-group>. <article-title>Congenital Alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibs</article-title>. <source/>Am J Med Genet. (<year>1996</year>) <volume>65</volume>:<fpage>167</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19961016)65:2&lt;167::AID-AJMG17&gt;3.0.CO;2-O</pub-id><pub-id pub-id-type="pmid">8911612</pub-id></mixed-citation>
</ref>
<ref id="B124">
<label>124.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Devlin</surname><given-names>BH</given-names></name><name><surname>Markert</surname><given-names>ML</given-names></name></person-group>. <article-title>Thymic microenvironment reconstitution after postnatal human thymus transplantation</article-title>. <source/>Clin Immunol. (<year>2011</year>) <volume>140</volume>:<fpage>244</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.clim.2011.04.004</pub-id><pub-id pub-id-type="pmid">21565561</pub-id></mixed-citation>
</ref>
<ref id="B125">
<label>125.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vigliano</surname><given-names>I</given-names></name><name><surname>Gorrese</surname><given-names>M</given-names></name><name><surname>Fusco</surname><given-names>A</given-names></name><name><surname>Vitiello</surname><given-names>L</given-names></name><name><surname>Amorosi</surname><given-names>S</given-names></name><name><surname>Panico</surname><given-names>L</given-names></name><etal></etal></person-group>. <article-title>FOXN1 mutation abrogates prenatal T-cell development in humans</article-title>. <source/>J Med Genet. (<year>2011</year>) <volume>48</volume>:<fpage>413</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2011.089532</pub-id><pub-id pub-id-type="pmid">21507891</pub-id></mixed-citation>
</ref>
<ref id="B126">
<label>126.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>J</given-names></name><name><surname>Massaad</surname><given-names>MJ</given-names></name><name><surname>Wakim</surname><given-names>RH</given-names></name><name><surname>Bainter</surname><given-names>W</given-names></name><name><surname>Dbaibo</surname><given-names>G</given-names></name><name><surname>Geha</surname><given-names>RS</given-names></name></person-group>. <article-title>A novel mutation in FOXN1 resulting in SCID: a case report and literature review</article-title>. <source/>Clin Immunol. (<year>2014</year>) <volume>155</volume>:<fpage>30</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1016/j.clim.2014.08.005</pub-id><pub-id pub-id-type="pmid">25173801</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radha Rama Devi</surname><given-names>A</given-names></name><name><surname>Panday</surname><given-names>NN</given-names></name><name><surname>Naushad</surname><given-names>SM</given-names></name></person-group>. <article-title>FOXN1 Italian founder mutation in Indian family: implications in prenatal diagnosis</article-title>. <source/>Gene. (<year>2017</year>) <volume>627</volume>:<fpage>222</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2017.06.033</pub-id><pub-id pub-id-type="pmid">28636882</pub-id></mixed-citation>
</ref>
<ref id="B128">
<label>128.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosticardo</surname><given-names>M</given-names></name><name><surname>Yamazaki</surname><given-names>Y</given-names></name><name><surname>Cowan</surname><given-names>J</given-names></name><name><surname>Giardino</surname><given-names>G</given-names></name><name><surname>Corsino</surname><given-names>C</given-names></name><name><surname>Scalia</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>Heterozygous FOXN1 variants cause low TRECs and severe T cell lymphopenia, revealing a crucial role of FOXN1 in supporting early thymopoiesis</article-title>. <source/>Am J Hum Genet. (<year>2019</year>) <volume>105</volume>:<fpage>549</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2019.07.014</pub-id><pub-id pub-id-type="pmid">31447097</pub-id></mixed-citation>
</ref>
<ref id="B129">
<label>129.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixit</surname><given-names>VD</given-names></name></person-group>. <article-title>Thymic fatness and approaches to enhance thymopoietic fitness in aging</article-title>. <source/>Curr Opin Immunol. (<year>2010</year>) <volume>22</volume>:<fpage>521</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.coi.2010.06.010</pub-id><pub-id pub-id-type="pmid">20650623</pub-id></mixed-citation>
</ref>
<ref id="B130">
<label>130.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nehls</surname><given-names>M</given-names></name><name><surname>Pfeifer</surname><given-names>D</given-names></name><name><surname>Schorpp</surname><given-names>M</given-names></name><name><surname>Hedrich</surname><given-names>H</given-names></name><name><surname>Boehm</surname><given-names>T</given-names></name></person-group>. <article-title>New member of the winged-helix protein family disrupted in mouse and rat nude mutations</article-title>. <source/>Nature. (<year>1994</year>) <volume>372</volume>:<fpage>103</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/372103a0</pub-id><pub-id pub-id-type="pmid">7969402</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>R</given-names></name><name><surname>Palamaro</surname><given-names>L</given-names></name><name><surname>Fusco</surname><given-names>A</given-names></name><name><surname>Giardino</surname><given-names>G</given-names></name><name><surname>Gallo</surname><given-names>V</given-names></name><name><surname>Del Vecchio</surname><given-names>L</given-names></name><etal></etal></person-group>. <article-title>FOXN1: a master regulator gene of thymic epithelial development program</article-title>. <source/>Front Immunol. (<year>2013</year>) <volume>4</volume>:<fpage>e187</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2013.00187</pub-id><pub-id pub-id-type="pmid">23874334</pub-id></mixed-citation>
</ref>
<ref id="B132">
<label>132.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Žuklys</surname><given-names>S</given-names></name><name><surname>Handel</surname><given-names>A</given-names></name><name><surname>Zhanybekova</surname><given-names>S</given-names></name><name><surname>Govani</surname><given-names>F</given-names></name><name><surname>Keller</surname><given-names>M</given-names></name><name><surname>Maio</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Foxn1 regulates key target genes essential for T cell development in postnatal thymic epithelial cells</article-title>. <source/>Nat Immunol. (<year>2016</year>) <volume>17</volume>:<fpage>1206</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3537</pub-id><pub-id pub-id-type="pmid">27548434</pub-id></mixed-citation>
</ref>
<ref id="B133">
<label>133.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schüddekopf</surname><given-names>K</given-names></name><name><surname>Schorpp</surname><given-names>M</given-names></name><name><surname>Boehm</surname><given-names>T</given-names></name></person-group>. <article-title>The whn transcription factor encoded by the nude locus contains an evolutionarily conserved and functionally indispensable activation domain</article-title>. <source/>Proc Natl Acad Sci USA. (<year>1996</year>) <volume>93</volume>:<fpage>9661</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.18.9661</pub-id><pub-id pub-id-type="pmid">8790387</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlake</surname><given-names>T</given-names></name><name><surname>Schorpp</surname><given-names>M</given-names></name><name><surname>Nehls</surname><given-names>M</given-names></name><name><surname>Boehm</surname><given-names>T</given-names></name></person-group>. <article-title>The nude gene encodes a sequence-specific DNA binding protein with homologs in organisms that lack an anticipatory immune system</article-title>. <source/>Proc Natl Acad Sci USA. (<year>1997</year>) <volume>94</volume>:<fpage>3842</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.8.3842</pub-id><pub-id pub-id-type="pmid">9108066</pub-id></mixed-citation>
</ref>
<ref id="B135">
<label>135.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>JA</given-names></name><name><surname>Aitkenhead</surname><given-names>H</given-names></name><name><surname>Gravard</surname><given-names>A</given-names></name><name><surname>Rota</surname><given-names>IA</given-names></name><name><surname>Handel</surname><given-names>AE</given-names></name><name><surname>Hollander</surname><given-names>GA</given-names></name><etal></etal></person-group>
<article-title>The structural basis for forkhead box family specificity revealed by the crystal structure of human FOXN1 in complex with DNA</article-title>. <source/>bioRxiv. (<year>2018</year>) <fpage>428011</fpage>
<pub-id pub-id-type="doi">10.1101/428011</pub-id></mixed-citation>
</ref>
<ref id="B136">
<label>136.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uddin</surname><given-names>MM</given-names></name><name><surname>Ohigashi</surname><given-names>I</given-names></name><name><surname>Motosugi</surname><given-names>R</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Sakata</surname><given-names>M</given-names></name><name><surname>Hamazaki</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Foxn1-beta5t transcriptional axis controls CD8(+) T-cell production in the thymus</article-title>. <source/>Nat Commun. (<year>2017</year>) <volume>8</volume>:<fpage>14419</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms14419</pub-id><pub-id pub-id-type="pmid">28176764</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schorpp</surname><given-names>M</given-names></name><name><surname>Schlake</surname><given-names>T</given-names></name><name><surname>Kreamalmeyer</surname><given-names>D</given-names></name><name><surname>Allen</surname><given-names>PM</given-names></name><name><surname>Boehm</surname><given-names>T</given-names></name></person-group>. <article-title>Genetically separable determinants of hair keratin gene expression</article-title>. <source/>Dev Dyn. (<year>2000</year>) <volume>218</volume>:<fpage>537</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1002/1097-0177(200007)218:3&lt;537::AID-DVDY1007&gt;3.0.CO;2-P</pub-id><pub-id pub-id-type="pmid">10878619</pub-id></mixed-citation>
</ref>
<ref id="B138">
<label>138.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potter</surname><given-names>CS</given-names></name><name><surname>Pruett</surname><given-names>ND</given-names></name><name><surname>Kern</surname><given-names>MJ</given-names></name><name><surname>Baybo</surname><given-names>MA</given-names></name><name><surname>Godwin</surname><given-names>AR</given-names></name><name><surname>Potter</surname><given-names>KA</given-names></name><etal></etal></person-group>. <article-title>The nude mutant gene Foxn1 is a HOXC13 regulatory target during hair follicle and nail differentiation</article-title>. <source/>J Invest Dermatol. (<year>2011</year>) <volume>131</volume>:<fpage>828</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1038/jid.2010.391</pub-id><pub-id pub-id-type="pmid">21191399</pub-id></mixed-citation>
</ref>
<ref id="B139">
<label>139.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flanagan</surname><given-names>SP</given-names></name></person-group>
<article-title>“Nude,” a new hairless gene with pleiotropic effects in the mouse</article-title>. <source/>Genet Res. (<year>1966</year>) <volume>8</volume>:<fpage>295</fpage>–<lpage>309</lpage>.<pub-id pub-id-type="pmid">5980117</pub-id></mixed-citation>
</ref>
<ref id="B140">
<label>140.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wortis</surname><given-names>HH</given-names></name><name><surname>Nehlsen</surname><given-names>S</given-names></name><name><surname>Owen</surname><given-names>JJ</given-names></name></person-group>. <article-title>Abnormal development of the thymus in “nude” mice</article-title>. <source/>J Exp Med. (<year>1971</year>) <volume>134</volume>:<fpage>681</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">15776569</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nehls</surname><given-names>M</given-names></name><name><surname>Kyewski</surname><given-names>B</given-names></name><name><surname>Messerle</surname><given-names>M</given-names></name><name><surname>Waldschütz</surname><given-names>R</given-names></name><name><surname>Schüddekopf</surname><given-names>K</given-names></name><name><surname>Smith</surname><given-names>AJH</given-names></name><etal></etal></person-group>. <article-title>Two genetically separable steps in the differentiation of thymic epithelium</article-title>. <source/>Science. (<year>1996</year>) <volume>272</volume>:<fpage>886</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1126/science.272.5263.886</pub-id><pub-id pub-id-type="pmid">8629026</pub-id></mixed-citation>
</ref>
<ref id="B142">
<label>142.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackburn</surname><given-names>CC</given-names></name><name><surname>Augustine</surname><given-names>CL</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Harvey</surname><given-names>RP</given-names></name><name><surname>Malin</surname><given-names>MA</given-names></name><name><surname>Boyd</surname><given-names>RL</given-names></name><etal></etal></person-group>. <article-title>The nu gene acts cell-autonomously and is required for differentiation of thymic epithelial progenitors</article-title>. <source/>Proc Natl Acad Sci USA. (<year>1996</year>) <volume>93</volume>:<fpage>5742</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">8650163</pub-id></mixed-citation>
</ref>
<ref id="B143">
<label>143.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Itoi</surname><given-names>M</given-names></name><name><surname>Tsukamoto</surname><given-names>N</given-names></name><name><surname>Amagai</surname><given-names>T</given-names></name></person-group>. <article-title>Foxn1 is essential for vascularization of the murine thymus anlage</article-title>. <source/>Cell Immunol. (<year>2010</year>) <volume>260</volume>:<fpage>66</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellimm.2009.09.007</pub-id><pub-id pub-id-type="pmid">19853842</pub-id></mixed-citation>
</ref>
<ref id="B144">
<label>144.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Festing</surname><given-names>MF</given-names></name><name><surname>May</surname><given-names>D</given-names></name><name><surname>Connors</surname><given-names>TA</given-names></name><name><surname>Lovell</surname><given-names>D</given-names></name><name><surname>Sparrow</surname><given-names>S</given-names></name></person-group>. <article-title>An athymic nude mutation in the rat</article-title>. <source/>Nature. (<year>1978</year>) <volume>274</volume>:<fpage>365</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/274365a0</pub-id><pub-id pub-id-type="pmid">307688</pub-id></mixed-citation>
</ref>
<ref id="B145">
<label>145.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuurman</surname><given-names>H-J</given-names></name><name><surname>Hougen</surname><given-names>HP</given-names></name><name><surname>Van Loveren</surname><given-names>H</given-names></name></person-group>
<article-title>The rnu (Rowett Nude) and rnuN (nznu, New Zealand Nude) Rat: an update</article-title>. <source/>ILAR J. (<year>1992</year>) <volume>34</volume>:<fpage>3</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1093/ilar.34.1-2.3</pub-id></mixed-citation>
</ref>
<ref id="B146">
<label>146.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abitbol</surname><given-names>M</given-names></name><name><surname>Bosse</surname><given-names>P</given-names></name><name><surname>Thomas</surname><given-names>A</given-names></name><name><surname>Tiret</surname><given-names>L</given-names></name></person-group>. <article-title>A deletion in FOXN1 is associated with a syndrome characterized by congenital hypotrichosis and short life expectancy in Birman cats</article-title>. <source/>PLoS ONE. (<year>2015</year>) <volume>10</volume>:<fpage>e0120668</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0120668</pub-id><pub-id pub-id-type="pmid">25781316</pub-id></mixed-citation>
</ref>
<ref id="B147">
<label>147.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>D-M</given-names></name><name><surname>Navarre</surname><given-names>S</given-names></name><name><surname>Oh</surname><given-names>W-J</given-names></name><name><surname>Condie</surname><given-names>BG</given-names></name><name><surname>Manley</surname><given-names>NR</given-names></name></person-group>. <article-title>A domain of Foxn1 required for crosstalk-dependent thymic epithelial cell differentiation</article-title>. <source/>Nat Immunol. (<year>2003</year>) <volume>4</volume>:<fpage>983</fpage>. <pub-id pub-id-type="doi">10.1038/ni983</pub-id><pub-id pub-id-type="pmid">14528302</pub-id></mixed-citation>
</ref>
<ref id="B148">
<label>148.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swann</surname><given-names>JB</given-names></name><name><surname>Weyn</surname><given-names>A</given-names></name><name><surname>Nagakubo</surname><given-names>D</given-names></name><name><surname>Bleul</surname><given-names>CC</given-names></name><name><surname>Toyoda</surname><given-names>A</given-names></name><name><surname>Happe</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>Conversion of the thymus into a bipotent lymphoid organ by replacement of FOXN1 with its paralog, FOXN4</article-title>. <source/>Cell Rep. (<year>2014</year>) <volume>8</volume>:<fpage>1184</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.07.017</pub-id><pub-id pub-id-type="pmid">25131198</pub-id></mixed-citation>
</ref>
<ref id="B149">
<label>149.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>BM</given-names></name><name><surname>Cowan</surname><given-names>JE</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Voisin</surname><given-names>B</given-names></name><etal></etal></person-group>
<article-title>Identification of an intronic regulatory element necessary for tissue-specific expression of Foxn1 in thymic epithelial cells</article-title>. <source/>J Immunol. (<year>2019</year>) <volume>203</volume>:<fpage>686</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1801540</pub-id><pub-id pub-id-type="pmid">31243087</pub-id></mixed-citation>
</ref>
<ref id="B150">
<label>150.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handel</surname><given-names>AE</given-names></name><name><surname>Holländer</surname><given-names>GA</given-names></name></person-group>. <article-title>Comment on “Identification of an intronic regulatory element necessary for tissue-specific expression of Foxn1 in thymic epithelial cells</article-title>.” <source/>J Immunol. (<year>2019</year>) <volume>203</volume>:<fpage>2355</fpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1900948</pub-id><pub-id pub-id-type="pmid">31636132</pub-id></mixed-citation>
</ref>
<ref id="B151">
<label>151.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>S</given-names></name><name><surname>Manley</surname><given-names>NR</given-names></name></person-group>. <article-title>Foxn1 is required to maintain the postnatal thymic microenvironment in a dosage-sensitive manner</article-title>. <source/>Blood. (<year>2009</year>) <volume>113</volume>:<fpage>567</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2008-05-156265</pub-id><pub-id pub-id-type="pmid">18978204</pub-id></mixed-citation>
</ref>
<ref id="B152">
<label>152.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zook</surname><given-names>EC</given-names></name><name><surname>Krishack</surname><given-names>PA</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zeleznik-Le</surname><given-names>NJ</given-names></name><name><surname>Firulli</surname><given-names>AB</given-names></name><name><surname>Witte</surname><given-names>PL</given-names></name><etal></etal></person-group>. <article-title>Overexpression of Foxn1 attenuates age-associated thymic involution and prevents the expansion of peripheral CD4 memory T cells</article-title>. <source/>Blood. (<year>2011</year>) <volume>118</volume>:<fpage>5723</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2011-03-342097</pub-id><pub-id pub-id-type="pmid">21908422</pub-id></mixed-citation>
</ref>
<ref id="B153">
<label>153.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reis</surname><given-names>MDDS</given-names></name><name><surname>Csomos</surname><given-names>K</given-names></name><name><surname>Dias</surname><given-names>LPB</given-names></name><name><surname>Prodan</surname><given-names>Z</given-names></name><name><surname>Szerafin</surname><given-names>T</given-names></name><name><surname>Savino</surname><given-names>W</given-names></name><etal></etal></person-group>. <article-title>Decline of FOXN1 gene expression in human thymus correlates with age: possible epigenetic regulation</article-title>. <source/>Immunity Ageing. (<year>2015</year>) <volume>12</volume>:<fpage>18</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1186/s12979-015-0045-9</pub-id><pub-id pub-id-type="pmid">26516334</pub-id></mixed-citation>
</ref>
<ref id="B154">
<label>154.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bredenkamp</surname><given-names>N</given-names></name><name><surname>Nowell</surname><given-names>CS</given-names></name><name><surname>Blackburn</surname><given-names>CC</given-names></name></person-group>. <article-title>Regeneration of the aged thymus by a single transcription factor</article-title>. <source/>Development. (<year>2014</year>) <volume>141</volume>:<fpage>1627</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1242/dev.103614</pub-id><pub-id pub-id-type="pmid">24715454</pub-id></mixed-citation>
</ref>
<ref id="B155">
<label>155.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Di</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>R</given-names></name><etal></etal></person-group>. <article-title>FOXN1 recombinant protein enhances T-cell regeneration after hematopoietic stem cell transplantation in mice</article-title>. <source/>Eur J Immunol. (<year>2016</year>) <volume>46</volume>:<fpage>1518</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201546196</pub-id><pub-id pub-id-type="pmid">27125859</pub-id></mixed-citation>
</ref>
<ref id="B156">
<label>156.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>ME</given-names></name></person-group>
<article-title>Undulated: a new genetic factor in mus musculus affecting the spine and tail</article-title>. <source/>Heredity. (<year>1947</year>) <volume>1</volume>:<fpage>137</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1038/hdy.1947.10</pub-id></mixed-citation>
</ref>
<ref id="B157">
<label>157.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>H</given-names></name><name><surname>Wilm</surname><given-names>B</given-names></name><name><surname>Sakai</surname><given-names>N</given-names></name><name><surname>Imai</surname><given-names>K</given-names></name><name><surname>Maas</surname><given-names>R</given-names></name><name><surname>Balling</surname><given-names>R</given-names></name></person-group>. <article-title>Pax1 and Pax9 synergistically regulate vertebral column development</article-title>. <source/>Development. (<year>1999</year>) <volume>126</volume>:<fpage>5399</fpage>–<lpage>408</lpage>.<pub-id pub-id-type="pmid">10556064</pub-id></mixed-citation>
</ref>
<ref id="B158">
<label>158.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>H</given-names></name><name><surname>Neubüser</surname><given-names>A</given-names></name><name><surname>Kratochwil</surname><given-names>K</given-names></name><name><surname>Balling</surname><given-names>R</given-names></name></person-group>. <article-title>Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities</article-title>. <source/>Genes Dev. (<year>1998</year>) <volume>12</volume>:<fpage>2735</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1101/gad.12.17.2735</pub-id><pub-id pub-id-type="pmid">9732271</pub-id></mixed-citation>
</ref>
<ref id="B159">
<label>159.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>W-C</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>C</given-names></name><name><surname>Kawaguchi</surname><given-names>A</given-names></name><name><surname>Takeda</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>Y-I</given-names></name><etal></etal></person-group>. <article-title>Association of common PAX9 variants with permanent tooth size variation in non-syndromic East Asian populations</article-title>. <source/>J Hum Genet. (<year>2012</year>) <volume>57</volume>:<fpage>654</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/jhg.2012.90</pub-id><pub-id pub-id-type="pmid">22810112</pub-id></mixed-citation>
</ref>
<ref id="B160">
<label>160.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucera</surname><given-names>J</given-names></name></person-group>. <article-title>Rate and type of congenital anomalies among offspring of diabetic women</article-title>. <source/>J Reprod Med. (<year>1971</year>) <volume>7</volume>:<fpage>73</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="pmid">5095696</pub-id></mixed-citation>
</ref>
<ref id="B161">
<label>161.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>JL</given-names></name></person-group>. <article-title>Malformations in infants of diabetic mothers</article-title>. <source/>Teratology. (<year>2010</year>) <volume>25</volume>:<fpage>385</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1002/bdra.20757</pub-id><pub-id pub-id-type="pmid">7051398</pub-id></mixed-citation>
</ref>
<ref id="B162">
<label>162.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacks</surname><given-names>DA</given-names></name><name><surname>Hadden</surname><given-names>DR</given-names></name><name><surname>Maresh</surname><given-names>M</given-names></name><name><surname>Deerochanawong</surname><given-names>C</given-names></name><name><surname>Dyer</surname><given-names>AR</given-names></name><name><surname>Metzger</surname><given-names>BE</given-names></name><etal></etal></person-group>. <article-title>Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study</article-title>. <source/>Diabetes Care. (<year>2012</year>) <volume>35</volume>:<fpage>526</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.2337/dc11-1641</pub-id><pub-id pub-id-type="pmid">22355019</pub-id></mixed-citation>
</ref>
<ref id="B163">
<label>163.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dornemann</surname><given-names>R</given-names></name><name><surname>Koch</surname><given-names>R</given-names></name><name><surname>Mollmann</surname><given-names>U</given-names></name><name><surname>Falkenberg</surname><given-names>MK</given-names></name><name><surname>Mollers</surname><given-names>M</given-names></name><name><surname>Klockenbusch</surname><given-names>W</given-names></name><etal></etal></person-group>. <article-title>Fetal thymus size in pregnant women with diabetic diseases</article-title>. <source/>J Perinat Med. (<year>2017</year>) <volume>45</volume>:<fpage>595</fpage>–<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1515/jpm-2016-0400</pub-id><pub-id pub-id-type="pmid">28195554</pub-id></mixed-citation>
</ref>
<ref id="B164">
<label>164.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padmanabhan</surname><given-names>R</given-names></name><name><surname>Shafiullah</surname><given-names>M</given-names></name></person-group>. <article-title>Effect of maternal diabetes and ethanol interactions on embryo development in the mouse</article-title>. <source/>Mol Cell Biochem. (<year>2004</year>) <volume>261</volume>:<fpage>43</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1023/b:mcbi.0000028736.00532.1e</pub-id><pub-id pub-id-type="pmid">15362484</pub-id></mixed-citation>
</ref>
<ref id="B165">
<label>165.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>LM</given-names></name><name><surname>Leung</surname><given-names>MB</given-names></name><name><surname>Kwok</surname><given-names>RC</given-names></name><name><surname>Leung</surname><given-names>YC</given-names></name><name><surname>Wang</surname><given-names>CC</given-names></name><name><surname>Mccaffery</surname><given-names>PJ</given-names></name><etal></etal></person-group>. <article-title>Perturbation of retinoid homeostasis increases malformation risk in embryos exposed to pregestational diabetes</article-title>. <source/>Diabetes. (<year>2017</year>) <volume>66</volume>:<fpage>1041</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.2337/db15-1570</pub-id><pub-id pub-id-type="pmid">28087565</pub-id></mixed-citation>
</ref>
<ref id="B166">
<label>166.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niederreither</surname><given-names>K</given-names></name><name><surname>Vermot</surname><given-names>J</given-names></name><name><surname>Le Roux</surname><given-names>I</given-names></name><name><surname>Schuhbaur</surname><given-names>B</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name><name><surname>Dolle</surname><given-names>P</given-names></name></person-group>. <article-title>The regional pattern of retinoic acid synthesis by RALDH2 is essential for the development of posterior pharyngeal arches and the enteric nervous system</article-title>. <source/>Development. (<year>2003</year>) <volume>130</volume>:<fpage>2525</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1242/dev.00463</pub-id><pub-id pub-id-type="pmid">12702665</pub-id></mixed-citation>
</ref>
<ref id="B167">
<label>167.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vermot</surname><given-names>J</given-names></name><name><surname>Niederreither</surname><given-names>K</given-names></name><name><surname>Garnier</surname><given-names>JM</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name><name><surname>Dolle</surname><given-names>P</given-names></name></person-group>. <article-title>Decreased embryonic retinoic acid synthesis results in a DiGeorge syndrome phenotype in newborn mice</article-title>. <source/>Proc Natl Acad Sci USA. (<year>2003</year>) <volume>100</volume>:<fpage>1763</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0437920100</pub-id><pub-id pub-id-type="pmid">12563036</pub-id></mixed-citation>
</ref>
<ref id="B168">
<label>168.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cipollone</surname><given-names>D</given-names></name><name><surname>Amati</surname><given-names>F</given-names></name><name><surname>Carsetti</surname><given-names>R</given-names></name><name><surname>Placidi</surname><given-names>S</given-names></name><name><surname>Biancolella</surname><given-names>M</given-names></name><name><surname>D'amati</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>A multiple retinoic acid antagonist induces conotruncal anomalies, including transposition of the great arteries, in mice</article-title>. <source/>Cardiovasc Pathol. (<year>2006</year>) <volume>15</volume>:<fpage>194</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.carpath.2006.04.004</pub-id><pub-id pub-id-type="pmid">16844550</pub-id></mixed-citation>
</ref>
<ref id="B169">
<label>169.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voss</surname><given-names>AK</given-names></name><name><surname>Vanyai</surname><given-names>HK</given-names></name><name><surname>Collin</surname><given-names>C</given-names></name><name><surname>Dixon</surname><given-names>MP</given-names></name><name><surname>Mclennan</surname><given-names>TJ</given-names></name><name><surname>Sheikh</surname><given-names>BN</given-names></name><etal></etal></person-group>. <article-title>MOZ regulates the Tbx1 locus, and Moz mutation partially phenocopies DiGeorge syndrome</article-title>. <source/>Dev Cell. (<year>2012</year>) <volume>23</volume>:<fpage>652</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2012.07.010</pub-id><pub-id pub-id-type="pmid">22921202</pub-id></mixed-citation>
</ref>
<ref id="B170">
<label>170.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhinn</surname><given-names>M</given-names></name><name><surname>Dollé</surname><given-names>P</given-names></name></person-group>. <article-title>Retinoic acid signalling during development</article-title>. <source/>Development. (<year>2012</year>) <volume>139</volume>:<fpage>843</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1242/dev.065938</pub-id><pub-id pub-id-type="pmid">22318625</pub-id></mixed-citation>
</ref>
<ref id="B171">
<label>171.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>C</given-names></name><name><surname>Ivins</surname><given-names>SM</given-names></name><name><surname>James</surname><given-names>CT</given-names></name><name><surname>Scambler</surname><given-names>PJ</given-names></name></person-group>. <article-title>Retinoic acid down-regulates Tbx1 expression <italic>in vivo</italic> and <italic>in vitro</italic></article-title>. <source/>Dev Dyn. (<year>2005</year>) <volume>232</volume>:<fpage>928</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.20268</pub-id><pub-id pub-id-type="pmid">15736167</pub-id></mixed-citation>
</ref>
<ref id="B172">
<label>172.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryckebusch</surname><given-names>L</given-names></name><name><surname>Bertrand</surname><given-names>N</given-names></name><name><surname>Mesbah</surname><given-names>K</given-names></name><name><surname>Bajolle</surname><given-names>F</given-names></name><name><surname>Niederreither</surname><given-names>K</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name><etal></etal></person-group>. <article-title>Decreased levels of embryonic retinoic acid synthesis accelerate recovery from arterial growth delay in a mouse model of DiGeorge syndrome</article-title>. <source/>Circ Res. (<year>2010</year>) <volume>106</volume>:<fpage>686</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.205732</pub-id><pub-id pub-id-type="pmid">20110535</pub-id></mixed-citation>
</ref>
<ref id="B173">
<label>173.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>CL</given-names></name><name><surname>Tallquist</surname><given-names>MD</given-names></name></person-group>. <article-title>PDGF function in diverse neural crest cell populations</article-title>. <source/>Cell Adh Migr. (<year>2010</year>) <volume>4</volume>:<fpage>561</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.4161/cam.4.4.12829</pub-id><pub-id pub-id-type="pmid">20657170</pub-id></mixed-citation>
</ref>
<ref id="B174">
<label>174.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>DL</given-names></name><name><surname>Gerlach-Bank</surname><given-names>LM</given-names></name><name><surname>Barald</surname><given-names>KF</given-names></name><name><surname>Koenig</surname><given-names>RJ</given-names></name></person-group>. <article-title>Retinoic acid repression of bone morphogenetic protein 4 in inner ear development</article-title>. <source/>Mol Cell Biol. (<year>2003</year>) <volume>23</volume>:<fpage>2277</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.23.7.2277-2286.2003</pub-id><pub-id pub-id-type="pmid">12640113</pub-id></mixed-citation>
</ref>
<ref id="B175">
<label>175.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipson</surname><given-names>AH</given-names></name><name><surname>Collins</surname><given-names>F</given-names></name><name><surname>Webster</surname><given-names>WS</given-names></name></person-group>. <article-title>Multiple congenital defects associated with maternal use of topical tretinoin</article-title>. <source/>Lancet. (<year>1993</year>) <volume>341</volume>:<fpage>1352</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/0140-6736(93)90868-h</pub-id><pub-id pub-id-type="pmid">8098487</pub-id></mixed-citation>
</ref>
<ref id="B176">
<label>176.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browne</surname><given-names>H</given-names></name><name><surname>Mason</surname><given-names>G</given-names></name><name><surname>Tang</surname><given-names>T</given-names></name></person-group>
<article-title>Retinoids and pregnancy: an update</article-title>. <source/>Obstetr Gynaecol. (<year>2014</year>) <volume>16</volume>:<fpage>7</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1111/tog.12075</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>